EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 32007R1451

Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)

OJ L 325, 11.12.2007, p. 3–65 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Special edition in Croatian: Chapter 03 Volume 055 P. 104 - 166

No longer in force, Date of end of validity: 29/10/2014; Repealed by 32014R1062 . Latest consolidated version: 01/09/2013

ELI: http://data.europa.eu/eli/reg/2007/1451/oj

11.12.2007   

EN

Official Journal of the European Union

L 325/3


COMMISSION REGULATION (EC) No 1451/2007

of 4 December 2007

on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (1), and in particular Article 16(2) thereof,

Whereas:

(1)

Pursuant to Directive 98/8/EC, Member States may only authorise the placing on the market of biocidal products containing active substances included in Annex I, IA or IB to that Directive. However, under the transitional measures provided for in Article 16(1) of Directive 98/8/EC Member States may allow the placing on the market of biocidal products containing active substances not listed in Annex I, IA or IB to Directive 98/8/EC which were already on the market on 14 May 2000, hereinafter ‘existing active substances’. Pursuant to paragraph 2 of that same Article, a 10-year programme of work is to be carried out for the review of all existing active substances. This programme of work was intended to identify the existing active substances and determine those to be evaluated under the review programme with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC.

(2)

The initial phase of the programme was laid down in Commission Regulation (EC) No 1896/2000 of 7 September 2000 on the first phase of the programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council on biocidal products (2).

(3)

Under Regulation (EC) No 1896/2000, existing active substances for use in biocidal products had to be identified, and those to be evaluated with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC in one or more product types had to be notified no later than 28 March 2002.

(4)

Commission Regulation (EC) No 2032/2003 of 4 November 2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC) No 1896/2000 (3) established a list of existing active substances. That list covered active substances that had been identified in accordance with Article 3(1) or Article 5(2) of Regulation (EC) No 1896/2000 or in respect of which equivalent information had been submitted in a notification in accordance with Article 4(1) of that Regulation.

(5)

Regulation (EC) No 2032/2003 also established, in Annex II, an exhaustive list of existing active substances to be evaluated under the review programme. That list covered active substances in respect of which at least one notification had been accepted in accordance with Article 4(2) of Regulation (EC) No 1896/2000 or in which a Member State had expressed an interest in accordance with Article 5(3) of that Regulation. That list specified the product types concerned.

(6)

Regulation (EC) No 2032/2003 allowed for a number of active substances or substance/product type combinations that were not originally covered by the review programme, to be examined on the same conditions as the active substances evaluated under the review programme, provided that interested operators submitted complete dossiers before 1 March 2006.

(7)

Article 4(2) of Regulation (EC) No 2032/2003 set 1 September 2006 as the date from which products containing active substances not examined under the review programme should be withdrawn from the market.

(8)

Article 4(3) of Regulation (EC) No 2032/2003 provided that the existing active substances that had not been identified by the persons using them in biocidal products were to be deemed not to have been placed on the market for biocidal purposes before 14 May 2000. However, this assimilation to new active substances should not be taken to mean that the unlawfully non-identified existing active substances may benefit from a provisional authorisation or from the longer data protection period reserved to genuinely new active substances. Whereas a clarification in that sense should be added to that provision.

(9)

Regulation (EC) No 2032/2003 introduced the possibility for Member States to apply for a derogation for biocidal products containing identified existing active substances that are not examined under the review programme, which Member States claim are essential for reasons of health, safety, or protection of cultural heritage or critical for the functioning of society in the absence of technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment or health. Such derogation is granted to the requesting Member States only if the requests are justified, if continued use does not give rise to concerns for human health and the environment, and if, where appropriate, alternatives are being developed. It is appropriate to continue to allow Member States to apply for such a derogation, including in respect of an active substance which it has been decided not to include in Annex I, IA or IB to Directive 98/8/EC. Since the review programme referred to in Article 16(2) of Directive 98/8/EC runs only until 14 May 2010, any such derogation should not continue beyond that date.

(10)

Certain substances or products that are normally consumed by humans or animals for their subsistence may also be used to attract or to repel harmful organisms. For these substances, there is general agreement that the authorisation/registration requirements of Directive 98/8/EC seem unjustified and that they should be expressly excluded from its scope. Considering that a revision of Directive 98/8/EC will take a significant amount of time during which the viability of those products on the market might be irreversibly affected, it is appropriate to postpone their withdrawal from the market until 14 May 2010.

(11)

A Member State which has indicated an interest in seeking review of a particular active substance should not be designated Rapporteur Member State for that substance.

(12)

In order to avoid duplication of work, and in particular to reduce testing involving vertebrate animals, the requirements concerning preparation and submission of the complete dossier should be such as to encourage those whose notifications have been accepted, hereinafter ‘participants’, to act collectively, in particular by submitting collective dossiers. It should be possible for the Rapporteur Member State to make available the reference to any test involving vertebrate animals that has been carried out in respect of a notified existing active substance unless that reference is confidential under Article 19 of Directive 98/8/EC. Also, in order to gain experience on the appropriateness of data requirements and to ensure that the review of active substances is carried out in a cost-effective way, participants should be encouraged to provide information on the costs of compiling a dossier and on the need to carry out tests on vertebrate animals.

(13)

In order to avoid delays, participants should start discussions as early as possible with Rapporteur Member States in order to resolve uncertainties in relation to data requirements. Applicants, other than participants, who wish to apply in accordance with Article 11 of Directive 98/8/EC for inclusion in Annex I, IA or IB thereto of an active substance/product type combination being evaluated under the review programme should submit complete dossiers for that combination no earlier or no later than participants so as not to disturb the smooth functioning of the review programme or create a disadvantage to the participants.

(14)

The requirements concerning the content and format of dossiers and the number of dossiers to be submitted should be defined.

(15)

Provision should be made for cases in which a participant is joined by a producer, formulator or association and in which a participant withdraws from the review programme.

(16)

Producers, formulators or associations should within certain time limits have the opportunity of taking over the role of participant for an existing active substance/product type combination in respect of which all participants have withdrawn or none of the dossiers meets the requirements. Subject to the same time-limits, it should also be possible in certain circumstances for Member States to indicate an interest and act as a participant for the inclusion in Annex I, IA or IB to Directive 98/8/EC of such a combination.

(17)

In order to discourage abuse of the opportunity to maintain an active substance on the market while it is examined under the review programme, it should be possible for another person or a Member State to take over the role of participant only once in relation to a given active substance/product type combination. For the same purpose, a person or Member State taking over the role of participant should provide within a certain period evidence of commencing work on a complete dossier.

(18)

Time limits should be specified within which the Rapporteur Member States must verify the completeness of the dossiers. It should be possible, in exceptional circumstances, for the Rapporteur Member States to establish a new deadline for the submission of parts of a dossier, in particular where the participant has demonstrated that it was impossible to submit information in due time or in order to resolve uncertainties regarding data requirements that remain despite earlier discussions between the participant and the Rapporteur Member State.

(19)

For each existing active substance, the Rapporteur Member State should examine and evaluate the dossier and present the results to the Commission and the other Member States in the form of a competent authority report and a recommendation as to the decision to be taken with regard to the active substance concerned. In order not to prolong decision-making unnecessarily, the Rapporteur Member State should at the same time consider carefully the need for additional studies. For the same reason, Rapporteur Member States should be obliged to take into consideration information submitted after acceptance of the dossier only under specified conditions.

(20)

The competent authority reports should be examined by the other Member States before the assessment reports are submitted to the Standing Committee on Biocidal Products.

(21)

Where, despite a recommendation for inclusion of an active substance in Annex I, IA or IB to Directive 98/8/EC, concerns as referred to in Article 10(5) of that Directive remain, it should be possible for the Commission to take into account, but without prejudice to Article 12 of that Directive, the finalisation of the evaluation on other existing active substances applied for the same use. Provision should be made for Rapporteur Member States to update competent authority reports where necessary.

(22)

In order to ensure better access to information, assessment reports should be drafted on the basis of the reports submitted by the competent authorities of the Member States and should be covered by the same rules regarding access to information as the reports of the competent authorities. The assessment reports should be derived from the original competent authority report as amended in the light of all the documents, comments and information taken into account during the evaluation process.

(23)

It should be possible to suspend the procedures provided for in this Regulation in the light of the application of other Community acts, in particular as regards Council Directive 76/769/EEC of 27 July 1976 on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (4), and after 1 June 2009, as regards Title VIII and Annex XVII of Regulation (EC) No 1907/2006.

(24)

In order to ensure the most efficient course of the review programme, a number of active substance/product type combinations have been reassigned to different rapporteur Member States. These developments should be reflected in Annex II of this Regulation.

(25)

Regulation (EC) No 2032/2003 has been amended on several occasions (5) in order to take into consideration the accession of new Member States, lessons learned from the implementation to date of the review programme, and in particular in order to provide for the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of a number of active substances, either because the requisite information was not submitted within the prescribed period or in cases where the requirements of Article 10 of the said Directive were not satisfied. This practice of constantly updating Regulation (EC) No 2032/2003 in order to follow the evolution of the review programme has proven ineffectual and time-consuming; furthermore it could create confusion to stakeholders as to which rules apply and which active substances are currently under review. In the interest of clarity, it is preferable to repeal and replace Regulation (EC) No 2032/2003 by a new simplified act which will lay down the rules for the review programme, and that the Commission should adopt separate acts for the future non-inclusion decisions.

(26)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS REGULATION:

Article 1

Subject matter

This Regulation lays down detailed rules for the implementation of the programme of work for the systematic examination of all active substances already on the market on 14 May 2000 as active substances of biocidal products, hereinafter ‘the review programme’, referred to in Article 16(2) of Directive 98/8/EC.

Article 2

Definitions

For the purposes of this Regulation the definitions in Article 2 of Directive 98/8/EC and Article 2 of Regulation (EC) No 1896/2000 shall apply.

In addition, ‘participant’ means a producer, formulator or association which has submitted a notification that has been accepted by the Commission in accordance with Article 4(2) of Regulation (EC) No 1896/2000 or a Member State which has indicated an interest in accordance with Article 5(3) of that Regulation.

Article 3

Existing active substances

1.   The list of active substances identified as available on the market before 14 May 2000 as active substances of biocidal products for purposes other than those referred to in Article 2(2)(c) and (d) of Directive 98/8/EC is set out in Annex I.

2.   The exhaustive list of existing active substances to be examined under the review programme is set out in Annex II.

The list includes the following active substances:

(a)

existing active substances notified in accordance with Article 4(1) of Regulation (EC) No 1896/2000 or Article 4(2) of Commission Regulation (EC) No 1687/2002 (6);

(b)

existing active substances that were not notified, but in respect of which a Member State has indicated an interest in supporting their inclusion in Annex I, IA or IB to Directive 98/8/EC;

(c)

existing active substances that were not notified, but for which a dossier was submitted to one of the Member States by 1 March 2006, which was found to comply with the requirements of Annex III to this Regulation and was accepted as complete.

The list specifies, for each existing active substance included, the product types in respect of which the substance will be examined under the review programme, as well as the Rapporteur Member State designated to carry out the evaluation.

Article 4

Non-inclusion

1.   Without prejudice to Articles 5 and 6 of this Regulation and paragraph 2 of this Article, biocidal products containing active substances not listed in Annex II to this Regulation or in Annex I or IA to Directive 98/8/EC shall no longer be placed on the market.

In the case of an active substance listed in Annex II to this Regulation, the first subparagraph shall also apply to that substance in relation to any product type not listed in that Annex.

2.   Biocidal products containing active substances listed in Annex II to this Regulation for which a decision was taken not to include these active substances for certain or all of their notified product types in Annex I or IA to Directive 98/8/EC, shall no longer be placed on the market for the product types concerned, with effect from 12 months after the date of such a measure being published, unless otherwise stipulated therein.

3.   Without prejudice to Articles 12(1)(b) and 15(2) of Directive 98/8/EC, from the day of entry into force of this Regulation, any active substance not listed in Annex I shall be deemed not to have been placed on the market for biocidal purposes before 14 May 2000.

Article 5

Derogation for essential use

1.   Member States may apply to the Commission for a derogation from Article 4(1) where they consider that an active substance is essential for them for reasons of health, safety or protection of cultural heritage or is critical for the functioning of society, and where there are no available technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment and health.

Applications shall be accompanied by a document stating the reasons and justifications.

2.   The applications referred to in paragraph 1 shall be forwarded by the Commission to the other Member States and shall be made publicly available by electronic means.

Member States or any person may for a period of 60 days following reception of an application submit comments in writing to the Commission.

3.   Taking account of the comments received, the Commission may grant a derogation from Article 4(1) allowing the placing of the substance on the market of the requesting Member States until 14 May 2010 at the latest, provided that the Member States:

(a)

ensure that continued use is possible only if products containing the substance are approved for the intended essential use;

(b)

conclude that, taking into account all available information, it is reasonable to assume that continued use does not have any unacceptable effect on human or animal health or on the environment;

(c)

impose all appropriate risk reduction measures when granting approval;

(d)

ensure that such approved biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the use conditions laid down by the Member States in accordance with this paragraph; and

(e)

ensure that, where appropriate, alternatives for such uses are being sought by the holders of the approvals or the Member States concerned, or a dossier is being prepared for submission in accordance with the procedure laid down in Article 11 of Directive 98/8/EC by 14 May 2008 at the latest.

4.   The Member States concerned shall annually inform the Commission on the application of paragraph 3 and in particular on the actions taken pursuant to point (e).

5.   Member States may at any time review the approvals of biocidal products for which the period of placing on the market has been extended in accordance with paragraph 3. Whenever there is reason to believe that any of the conditions set in points (a) to (e) of that paragraph are no longer satisfied, the Member States concerned shall without undue delay take steps to remedy the situation or if that is not possible, withdraw the approvals of the biocidal products concerned.

Article 6

Food and Feed

By way of derogating from Article 4(1), Member States may allow until 14 May 2010 at the latest the placing on the market of active substances consisting solely of food or feed that are intended for use as repellents or attractants of product type 19.

For the purposes of this derogation, ‘food or feed’ means any edible substance or product of plant or animal origin, whether processed, partially processed or unprocessed, which is intended or reasonably expected to be ingested by humans or animals; this category does not comprise extracts or individual substances isolated from food or feed.

Article 7

Examination of existing active substances under the review programme

1.   The review of an active substance listed in Annex II, in respect of the product types specified, shall be undertaken by the Rapporteur Member State designated for that purpose on the basis of the complete dossier for that substance/product type combination, provided that:

(a)

the dossier complies with the requirements set out in Annex III to this Regulation;

(b)

the complete dossier is submitted within the period specified in Article 9 of this Regulation for the product type concerned, together with the summary dossier referred to in Article 11(1)(b) of Directive 98/8/EC and defined in Annex III to this Regulation.

An active substance listed in Annex II to this Regulation shall be reviewed exclusively in relation to the product types specified therein.

For the active substance/product type combinations referred to in Article 3(2)(c), with the exception of product types 8 and 14, the evaluation of the dossiers shall commence at the same time as the evaluation of dossiers for active substances contained in the same product types.

2.   A Member State which has indicated an interest in supporting the inclusion of an active substance in Annex I, IA or IB to the Directive shall not be designated as Rapporteur Member State in respect of that substance.

3.   Without prejudice to Articles 10, 11 and 12 of this Regulation, persons other than participants may apply, in accordance with Article 11 of Directive 98/8/EC, for the inclusion in Annex I, IA or IB thereto of an existing active substance/product type combination that is listed in Annex II to this Regulation. These persons shall submit in that case a complete dossier within the time period specified in Article 9 for that substance/product type combination.

Article 8

Preparation of the complete dossier

1.   In the preparation of the complete dossier, all reasonable efforts shall be made, inter alia, to avoid duplication of testing on vertebrate animals and, where appropriate, to establish a collective complete dossier.

2.   Before commencing compilation of the complete dossier, a participant shall:

(a)

inform the Rapporteur Member State of any testing on vertebrate animals that it has already carried out;

(b)

contact the Rapporteur Member State for advice as to the acceptability of justifications for waiving certain studies;

(c)

inform the Rapporteur Member State of any intention to carry out further testing on vertebrate animals for the purposes of the complete dossier;

(d)

when informed by the Rapporteur Member State that another participant has notified plans to carry out the same tests, make all reasonable efforts to cooperate with that participant in the performance of common testing.

Advice given by Rapporteur Member States in accordance with point (b) of the first subparagraph shall not predetermine the outcome of the completeness check under Article 13(1).

3.   A Rapporteur Member State may make available the reference to any test carried out on vertebrate animals in respect of an active substance listed in Annex II to this Regulation, save where that reference is to be treated as confidential in accordance with Article 19 of Directive 98/8/EC. Such reference may include the name of the active substance concerned, the end points of the tests, and the contact address of the data owner.

4.   Where a Rapporteur Member State is aware that more than one participant is seeking review of a particular active substance, it shall inform those participants accordingly.

5.   Participants seeking review of the same active substance for the same product types shall undertake all reasonable efforts to submit a collective complete dossier, while fully respecting the Community rules on competition.

Where, in those circumstances, a collective dossier is not submitted, each individual dossier shall detail the efforts made to secure cooperation and the reasons for non-participation.

6.   Details shall be given in the complete dossier and in the summary dossier of the efforts made to avoid duplication of testing on vertebrate animals.

7.   In order to provide information on the costs entailed in applying for review and on the need for animal testing for the purposes of compiling the complete dossier, participants may submit to the Rapporteur Member State together with the complete dossiers a breakdown of the costs of the respective actions and studies carried out.

The Rapporteur Member State shall communicate that information to the Commission when submitting the competent authority report in accordance with Article 14(4).

8.   Information on the costs entailed in compiling the complete dossier and on the animal testing carried out for that purpose shall be included in the report referred to in Article 18(5) of Directive 98/8/EC together with any appropriate recommendations concerning modifications of data requirements in order to reduce to a minimum the need for testing on vertebrate animals, and to ensure cost-effectiveness and proportionality.

Article 9

Submission of the complete dossier

1.   Unless otherwise indicated by the Rapporteur Member State, a participant shall submit to the Rapporteur Member State one paper and one electronic copy of the complete dossier.

The participant shall also, in accordance with Article 13(3), submit one paper and one electronic copy of the summary dossier to the Commission and to each of the other Member States. However, any Member State wishing to receive copies only in electronic format or additional copies shall inform the Commission, which shall make that information publicly available by electronic means. If the Member State subsequently decides otherwise, it shall inform the Commission without undue delay, whereupon the Commission shall update accordingly the information made publicly available.

2.   For the existing active substances listed in Annex II, complete dossiers must be received by the competent authority of the Rapporteur Member State within the following periods:

(a)

for product types 8 and 14, until 28 March 2004;

(b)

for product types 16, 18, 19 and 21, from 1 November 2005 until 30 April 2006;

(c)

for product types 1, 2, 3, 4, 5, 6 and 13, from 1 February 2007 until 31 July 2007;

(d)

for product types 7, 9, 10, 11, 12, 15, 17, 20, 22 and 23, from 1 May 2008 until 31 October 2008.

Article 10

Joining and replacing of participants

Where, by mutual agreement, a producer, formulator or association joins or replaces a participant for the purposes of submitting the complete dossier, all parties to the agreement shall jointly inform the Commission and the Rapporteur Member State accordingly, attaching any relevant letter of access.

The Commission shall inform accordingly any other participant seeking review of the same active substance in relation to the same product types.

Article 11

Withdrawal of participants

1.   Where a participant intends to discontinue participation in the review programme, they shall inform the relevant Rapporteur Member State and the Commission accordingly, in writing and without delay, stating the reasons.

The Commission shall inform accordingly the other Member States and any other participant seeking review of the same active substance in relation to the same product type(s).

2.   Where all the participants have withdrawn as regards a particular existing active substance/product type combination, the Commission shall inform the Member States thereof and shall publish that information electronically.

Article 12

Taking over the role of participant

1.   Within three months of the electronic publication of the information referred to in Article 11(2), a producer, formulator, association or other person may inform the Commission of their intention to take over the role of participant as regards the existing active substance/product type combination.

Within the time period referred to in the first subparagraph, a Member State may also indicate to the Commission an interest in taking over the role of participant in order to support the inclusion in Annex I, IA or IB to Directive 98/8/EC of the existing active substance/product type combination, where there are uses which the Member State considers essential, in particular for the protection of human health, animal health or the environment.

2.   The person or Member State wishing to take over the role of the participant who has withdrawn shall, within three months of informing the Commission of their intention, provide evidence to it that work to compile a complete dossier has been commissioned.

3.   On the basis of the evidence referred to in paragraph 2, the Commission shall decide whether or not to allow the interested person or Member State to take over the role of participant.

Where the Commission allows the interested person or Member State to take over the role of participant, it may decide to extend, if necessary, the relevant period for the submission of a complete dossier specified in Article 9.

4.   The taking over of the role of participant for a given existing active substance/product type combination may be allowed only once.

5.   Where the Commission receives no response pursuant to paragraph 1, it shall take a decision not to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC within the framework of the review programme for the product type(s) concerned.

Article 13

Completeness check of dossiers

1.   Within three months of receiving the dossier for an existing active substance/product type combination and no later than three months after the end of the relevant time period specified in Article 9(2) of this Regulation, the Rapporteur Member State shall verify whether the dossier is to be accepted as complete in accordance with Article 11(1)(b) of Directive 98/8/EC.

Where the Rapporteur Member State has initiated consultations with other Member States and the Commission in relation to the acceptability of a dossier, the period may be prolonged until consultations have been finalised, up to a maximum of six months from receipt of the dossier.

2.   A Rapporteur Member State may require, as a condition for considering a dossier to be complete, proof of advance payment, in full or in part, of the charges payable under Article 25 of Directive 98/8/EC to be provided in the dossier.

3.   Where a dossier is considered to be complete, the Rapporteur Member State shall confirm acceptance of the dossier to the participant and agree to the participant forwarding the summary dossier to the Commission and the other Member States within one month of receiving the confirmation.

If a Member State in receipt of a summary dossier has legitimate reason to believe that the dossier is incomplete, it shall without delay communicate its concerns to the Rapporteur Member State, the Commission and the other Member States.

The Rapporteur Member State shall immediately take up consultations with that Member State and the Commission in order to discuss the concern expressed and resolve divergent opinions.

4.   In exceptional circumstances, the Rapporteur Member State may establish a new deadline for the submission of information which, for reasons duly substantiated, the participant was unable to submit in due time.

The participant shall, within three months of being informed of the new deadline, provide evidence to the Rapporteur Member State that work to provide the missing information has been commissioned.

If the Rapporteur Member State considers that it has received sufficient evidence, it shall carry out its evaluation in accordance with Article 14 as if the dossier were complete. Otherwise, the evaluation shall not commence until the missing information is submitted.

5.   Where a complete dossier is not received within the period specified in Article 9 or by a new deadline established in accordance with paragraph 4, the Rapporteur Member State shall inform the Commission, giving the reasons put forward by the participant by way of justification.

The Rapporteur Member State shall also inform the Commission in cases where a participant fails to provide the evidence required in accordance with the second subparagraph of paragraph 4. In the cases referred to in the first and second subparagraphs and if no other dossier concerns the same existing active substance/product type combination, all participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis.

Article 14

Evaluation of dossiers by the Rapporteur Member State

1.   Where the Rapporteur Member State considers a dossier to be complete, it shall carry out the evaluation within twelve months of accepting the dossier in accordance with Article 11(2) of Directive 98/8/EC and shall prepare a report on that evaluation, hereinafter ‘the competent authority report’.

Without prejudice to Article 12 of Directive 98/8/EC, the Rapporteur Member State may take into account other relevant technical or scientific information regarding the properties of the active substance, metabolites or residues.

2.   At the request of a participant, the Rapporteur Member State may take into account additional information relating to an active substance for which the dossier has been accepted as complete only if the following conditions are fulfilled:

(a)

the participant informed the Rapporteur Member State, at the time of submission of the dossier, that preparation of the additional information was under way;

(b)

the additional information is submitted no later than nine months after acceptance of the dossier in accordance with Article 13(3);

(c)

by comparison with the data originally submitted, the additional information is equally or more reliable owing to the application of the same or higher quality standards;

(d)

by comparison with the data originally submitted, the additional information supports a different conclusion concerning the active substance for the purposes of the recommendation under paragraph 6.

The Rapporteur Member State shall take into account additional information submitted by persons other than the participant only if that information satisfies the conditions set out in points (b), (c) and (d) of the first subparagraph.

3.   Where relevant in the application of paragraph 1, in particular when additional information has been requested by a deadline established by the Rapporteur Member State, the latter may request that the participant submit updated summary dossiers to the Commission and the other Member States when the additional information is received.

All participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis if:

(a)

the additional information is not received by the deadline;

(b)

the participant fails to provide adequate justification for further postponing the deadline;

(c)

no other dossier concerns the same existing active substance/product type combination.

4.   The Rapporteur Member State shall, without undue delay, send a copy of the competent authority report to the Commission, the other Member States and to the participant.

5.   A Rapporteur Member State may decide to withhold the competent authority report if the charges payable under Article 25 of Directive 98/8/EC have not been paid in full, in which case it shall inform the participant and the Commission accordingly.

All participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis if:

(a)

full payment is not received within three months of the date of receipt of that information;

(b)

no other dossier concerns the same existing active substance/product type combination.

6.   The competent authority report shall be presented in a format to be recommended by the Commission and shall include one of the following:

(a)

a recommendation to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC, stating, where appropriate, conditions for inclusion;

(b)

a recommendation not to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC, stating the reasons.

Article 15

Commission procedures

1.   When the Commission receives a competent authority report pursuant to Article 14(4) of this Regulation it shall, without undue delay, prepare the draft decision referred to in Article 27 of Directive 98/8/EC.

2.   Before preparing the draft decision referred to in paragraph 1, the Commission shall, when necessary in the light of the comments received on the competent authority report, consult with experts from the Member States to address any problems remaining unresolved. Where necessary and upon a request from the Commission, the Rapporteur Member State shall prepare an updated competent authority report.

3.   Where an existing active substance, despite a recommendation for inclusion pursuant to Article 14(6) of this Regulation, still gives rise to concern, as referred to in Article 10(5) of Directive 98/8/EC, the Commission may, without prejudice to Article 12 of that Directive, take into account the finalisation of the evaluation of other existing active substances applied for the same use.

4.   On the basis of the documents and information referred to in Article 27(2) of Directive 98/8/EC, the Rapporteur Member State shall prepare an updated competent authority report, the first part of which shall form the assessment report. The assessment report shall be reviewed within the Standing Committee on Biocidal Products. Where several dossiers have been submitted for the same active substance/product type combination, the Rapporteur Member State shall prepare one assessment report based on the information contained in those dossiers.

Article 16

Access to information

Where a Rapporteur Member State has submitted the competent authority report in accordance with Article 14(4) of this Regulation, or where an assessment report has been finalised or updated in the Standing Committee on Biocidal Products, the Commission shall make the report or any updates thereof publicly available by electronic means, except for information that is to be treated as confidential in accordance with Article 19 of Directive 98/8/EC.

Article 17

Suspension of procedures

Where, in respect of an active substance listed in Annex II to this Regulation, the Commission presents a proposal for amending Directive 76/769/EEC or, with effect from 1 June 2009, Annex XVII of Regulation (EC) No 1907/2006 in order to prohibit its placing on the market or its use, including use for biocidal purposes, in certain or all product types, the procedures provided for in this Regulation concerning that substance for use in the product types concerned may be suspended pending a decision on that proposal.

Article 18

Repeal

Regulation (EC) No 2032/2003 is repealed.

References to the repealed Regulation shall be construed as references to this Regulation.

Article 19

Entry into force

This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 4 December 2007.

For the Commission

Stavros DIMAS

Member of the Commission


(1)  OJ L 123, 24.4.1998, p. 1. Directive as last amended by Directive 2007/47/EC (OJ L 247, 21.9.2007, p. 21).

(2)  OJ L 228, 8.9.2000, p. 6. Regulation as amended by Regulation (EC) No 2032/2003 (OJ L 307, 24.11.2003, p. 1).

(3)  OJ L 307, 24.11.2003, p. 1. Regulation as last amended by Regulation (EC) No 1849/2006 (OJ L 355, 15.12.2006, p. 63).

(4)  OJ L 262, 27.9.1976, p. 201. Directive as last amended by Directive 2007/51/EC of the European Parliament and of the Council (OJ L 257, 3.10.2007, p. 13).

(5)  By Regulation (EC) No 1048/2005 (OJ L 178, 9.7.2005, p. 1); and Regulation (EC) No 1849/2006, (OJ L 355, 15.12.2006, p. 63).

(6)  OJ L 258, 26.9.2002, p. 15.


ANNEX I

ACTIVE SUBSTANCES IDENTIFIED AS EXISTING

Name (EINECS and/or others)

EC number

CAS number

Formaldehyde

200-001-8

50-00-0

Ergocalciferol/Vitamin D2

200-014-9

50-14-6

Lactic acid

200-018-0

50-21-5

Clofenotane/DDT

200-024-3

50-29-3

Ascorbic acid

200-066-2

50-81-7

2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide

200-076-7

51-03-6

2,4-dinitrophenol

200-087-7

51-28-5

2-imidazol-4-ylethylamine

200-100-6

51-45-6

Bronopol

200-143-0

52-51-7

Trichlorfon

200-149-3

52-68-6

Sodium salicylate

200-198-0

54-21-7

Fenthion

200-231-9

55-38-9

Glycerol trinitrate

200-240-8

55-63-0

Bis(tributyltin) oxide

200-268-0

56-35-9

Tributyltin acetate

200-269-6

56-36-0

Coumaphos

200-285-3

56-72-4

Glycerol

200-289-5

56-81-5

Chlorhexidine diacetate

200-302-4

56-95-1

Allyl isothiocyanate

200-309-2

57-06-7

Cetrimonium bromide/Hexadecyltrimethylammonium bromide

200-311-3

57-09-0

Urea

200-315-5

57-13-6

Strychnine

200-319-7

57-24-9

Propane-1,2-diol

200-338-0

57-55-6

Ethinylestradiol

200-342-2

57-63-6

Caffeine

200-362-1

58-08-2

Diphenoxarsin-10-yl oxide

200-377-3

58-36-6

Gamma-HCH or Gamma-BHC/Lindane/1,2,3,4,5,6-hexachlorocyclohexane

200-401-2

58-89-9

Sulfaquinoxaline

200-423-2

59-40-5

Chlorocresol

200-431-6

59-50-7

2-phenylethanol

200-456-2

60-12-8

Dimethoate

200-480-3

60-51-5

Methylthioninium chloride

200-515-2

61-73-4

Thiourea

200-543-5

62-56-6

Dichlorvos

200-547-7

62-73-7

Carbaryl

200-555-0

63-25-2

Ethanol

200-578-6

64-17-5

Formic acid

200-579-1

64-18-6

Acetic acid

200-580-7

64-19-7

Benzoic acid

200-618-2

65-85-0

Propan-2-ol

200-661-7

67-63-0

Chloroform/Trichloromethane

200-663-8

67-66-3

Colecalciferol

200-673-2

67-97-0

Salicylic acid

200-712-3

69-72-7

Hexachlorophene

200-733-8

70-30-4

Propan-1-ol

200-746-9

71-23-8

Butan-1-ol

200-751-6

71-36-3

Methoxychlor

200-779-9

72-43-5

Bromomethane/Methyl bromide

200-813-2

74-83-9

Hydrogen cyanide

200-821-6

74-90-8

Metaldehyde

200-836-8

9002-91-9

Carbon disulfide

200-843-6

75-15-0

Ethylene oxide

200-849-9

75-21-8

Iodoform/Triiodomethane

200-874-5

75-47-8

Tert-butyl hydroperoxide

200-915-7

75-91-2

Trichloronitromethane

200-930-9

76-06-2

Bornan-2-one/Campher

200-945-0

76-22-2

(3aS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-2,10-dimethoxy-3,8,11a,11c-tetramethyldibenzo[de,g]chromene-1,5,11-trione/Quassin

200-985-9

76-78-8

1,3-dibromo-5,5-dimethylhydantoin

201-030-9

77-48-5

3-beta-hydroxyurs-12-en-28-oic acid/Ursolic acid

201-034-0

77-52-1

Citric acid

201-069-1

77-92-9

Citric acid monohydrate

201-069-1

5949-29-1

1,3,4,5-tetrahydroxycyclohexanecarboxylic acid

201-072-8

77-95-2

Linalool

201-134-4

78-70-6

2-methylpropan-1-ol

201-148-0

78-83-1

2-chloroacetamide

201-174-2

79-07-2

Bromoacetic acid

201-175-8

79-08-3

Propionic acid

201-176-3

79-09-4

Chloroacetic acid

201-178-4

79-11-8

Glycollic acid

201-180-5

79-14-1

Peracetic acid

201-186-8

79-21-0

L-(+)-lactic acid

201-196-2

79-33-4

p-(1,1-dimethylpropyl)phenol

201-280-9

80-46-6

Pin-2(3)-ene

201-291-9

80-56-8

Sennoside A

201-339-9

81-27-6

Warfarin

201-377-6

81-81-2

Coumachlor

201-378-1

81-82-3

Diphacinone

201-434-5

82-66-6

Ethyl quinine carbonate

201-500-3

83-75-0

(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one/Rotenone

201-501-9

83-79-4

Anthraquinone

201-549-0

84-65-1

Dibutyl phthalate

201-557-4

84-74-2

Salicylanilide

201-727-8

87-17-2

(+)-tartaric acid

201-766-0

87-69-4

Pentachlorophenol

201-778-6

87-86-5

Symclosene

201-782-8

87-90-1

Chloroxylenol

201-793-8

88-04-0

2,4,6-trichlorophenol

201-795-9

88-06-2

Menthol

201-939-0

89-78-1

Isopulegol

201-940-6

89-79-2

Thymol

201-944-8

89-83-8

Guaiacol/2-methoxyphenol

201-964-7

90-05-1

Biphenyl-2-ol

201-993-5

90-43-7

Naphthalene

202-049-5

91-20-3

Propyl 4-hydroxybenzoate

202-307-7

94-13-3

Butyl 4-hydroxybenzoate

202-318-7

94-26-8

Dibenzoyl peroxide

202-327-6

94-36-0

2-ethylhexane-1,3-diol

202-377-9

94-96-2

Benzotriazole

202-394-1

95-14-7

3-chloropropane-1,2-diol

202-492-4

96-24-2

Dichlorophen

202-567-1

97-23-4

Eugenol

202-589-1

97-53-0

Allantoin

202-592-8

97-59-6

Methyl 4-hydroxybenzoate

202-785-7

99-76-3

Benzyl alcohol

202-859-9

100-51-6

2,2′-[(1,1,3-trimethylpropane-1,3-diyl)bis(oxy)]bis[4,4,6-trimethyl-1,3,2-dioxaborinane]

202-899-7

100-89-0

Methenamine/Hexamethylenetetramine

202-905-8

100-97-0

Triclocarban

202-924-1

101-20-2

Chlorpropham

202-925-7

101-21-3

1,1′,1″,1‴!-ethylenedinitrilotetrapropan-2-ol

203-041-4

102-60-3

2,2′,2″-nitrilotriethanol

203-049-8

102-71-6

Chlorphenesin

203-192-6

104-29-0

Anethole

203-205-5

104-46-1

Cinnamaldehyde/3-phenyl-propen-2-al

203-213-9

104-55-2

2-ethylhexan-1-ol/Isooctanol

203-234-3

104-76-7

Citronellol

203-375-0

106-22-9

Citronellal

203-376-6

106-23-0

Geraniol

203-377-1

106-24-1

1,4-dichlorobenzene

203-400-5

106-46-7

Ethylendiamine

203-468-6

107-15-3

Chloro-acetaldehyde

203-472-8

107-20-0

Ethane-1,2-diol

203-473-3

107-21-1

Glyoxal

203-474-9

107-22-2

Methyl formate

203-481-7

107-31-3

Butane-1,3-diol

203-529-7

107-88-0

Vinyl acetate

203-545-4

108-05-4

Acetic anhydride

203-564-8

108-24-7

m-Cresol

203-577-9

108-39-4

Resorcinol

203-585-2

108-46-3

Cyanuric acid

203-618-0

108-80-5

Phenol

203-632-7

108-95-2

Ethyl formate

203-721-0

109-94-4

Succinic acid

203-740-4

110-15-6

Hexa-2,4-dienoic acid/Sorbic acid

203-768-7

110-44-1

Pyridine

203-809-9

110-86-1

Morpholine

203-815-1

110-91-8

Glutaral

203-856-5

111-30-8

2-Butoxyethanol

203-905-0

111-76-2

Cetrimonium chloride/Hexadecyl-trimethylammoniumchloride

203-928-6

112-02-7

Nonanoic acid

203-931-2

112-05-0

Undecan-2-one/Methyl-nonyl-ketone

203-937-5

112-12-9

2,2′-(ethylenedioxy)diethanol/Triethylene-glycol

203-953-2

112-27-6

Undec-10-enoic acid

203-965-8

112-38-9

Oleic acid

204-007-1

112-80-1

(Z)-docos-13-enoic acid

204-011-3

112-86-7

N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide

204-029-1

113-48-4

Propoxur

204-043-8

114-26-1

Endosulfan

204-079-4

115-29-7

1,7,7-trimethylbicyclo[2.2.1]hept-2-yl thiocyanatoacetate

204-081-5

115-31-1

Dicofol

204-082-0

115-32-2

Linalyl acetate

204-116-4

115-95-7

3,3′,4′,5,7-pentahydroxyflavone

204-187-1

117-39-5

1,3-dichloro-5,5-dimethylhydantoin

204-258-7

118-52-5

Methyl salicylate

204-317-7

119-36-8

Clorophene

204-385-8

120-32-1

Ethyl 4-hydroxybenzoate

204-399-4

120-47-8

Benzyl benzoate

204-402-9

120-51-4

Piperonal

204-409-7

120-57-0

Indole

204-420-7

120-72-9

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl-2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-cyclopropanecarboxylate/Cinerin II

204-454-2

121-20-0

2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)],3.beta.]]-chrysanthemate/Pyrethrin I

204-455-8

121-21-1

2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)](3.beta.)-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate/Pyrethrin II

204-462-6

121-29-9

Benzethonium chloride

204-479-9

121-54-0

5-nitrothiazol-2-ylamine

204-490-9

121-66-4

Malathion

204-497-7

121-75-5

Fenitrothion

204-524-2

122-14-5

Cetalkonium chloride

204-526-3

122-18-9

Benzyldimethyl(octadecyl)ammonium chloride

204-527-9

122-19-0

Simazine

204-535-2

122-34-9

Propham

204-542-0

122-42-9

4-Phenylbutanone

204-555-1

122-57-6

2-Phenoxyethanol

204-589-7

122-99-6

Cetylpyridinium chloride

204-593-9

123-03-5

Cetylpyridinium chloride monohydrate

204-593-9

6004-24-6

2-Ethylhexanal

204-596-5

123-05-7

Pyridazine-3,6-diol/Maleic hydrazide

204-619-9

123-33-1

Adipic acid

204-673-3

124-04-9

Octanoic acid

204-677-5

124-07-2

Dodecylamine/Laurylamine

204-690-6

124-22-1

Carbon dioxide

204-696-9

124-38-9

Sodium dimethylarsinate

204-708-2

124-65-2

Exo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol

204-712-4

124-76-5

Nitromethylidynetrimethanol

204-769-5

126-11-4

Sodium acetate

204-823-8

127-09-3

Sodium N-chlorobenzenesulphonamide

204-847-9

127-52-6

Tosylchloramide sodium

204-854-7

127-65-1

Bis(2,3,3,3-tetrachloropropyl) ether

204-870-4

127-90-2

Potassium dimethyldithiocarbamate

204-875-1

128-03-0

Sodium dimethyldithiocarbamate

204-876-7

128-04-1

N-bromosuccinimide

204-877-2

128-08-5

N-chlorosuccinimide

204-878-8

128-09-6

2,6-di-tert-butyl-p-cresol

204-881-4

128-37-0

Warfarin sodium

204-929-4

129-06-6

Dimethyl phthalate

205-011-6

131-11-3

Sodium pentachlorophenolate

205-025-2

131-52-2

Sodium 2-biphenylate

205-055-6

132-27-4

Sodium 2-biphenylate tetrahydrate

205-055-6

6152-33-6

Captan

205-087-0

133-06-2

N-(trichloromethylthio)phthalimide/Folpet

205-088-6

133-07-3

2,4-Dichloro-3,5-xylenol

205-109-9

133-53-9

Methyl anthranilate

205-132-4

134-20-3

Bis(8-hydroxyquinolinium) sulphate

205-137-1

134-31-6

N,N-diethyl-m-toluamide

205-149-7

134-62-3

Dipropyl pyridine-2,5-dicarboxylate

205-245-9

136-45-8

Zinc bis(2-ethylhexanoate)

205-251-1

136-53-8

6-methylbenzotriazole

205-265-8

136-85-6

Thiram

205-286-2

137-26-8

Ziram

205-288-3

137-30-4

Sodium propionate

205-290-4

137-40-6

Potassium methyldithiocarbamate

205-292-5

137-41-7

Metam-sodium

205-293-0

137-42-8

Dipentene

205-341-0

138-86-3

Disodium cyanodithiocarbamate

205-346-8

138-93-2

Benzododecinium chloride

205-351-5

139-07-1

Miristalkonium chloride

205-352-0

139-08-2

Nitrilo triacetic acid

205-355-7

139-13-9

p-tolyl acetate

205-413-1

140-39-6

1,3-bis(hydroxymethyl)urea

205-444-0

140-95-4

Sodium formate

205-488-0

141-53-7

2,3-dihydroxypropyl laurate

205-526-6

142-18-7

Nabam

205-547-0

142-59-6

Hexanoic acid

205-550-7

142-62-1

Lauric acid

205-582-1

143-07-7

Potassium oleate

205-590-5

143-18-0

Sodium hydrogencarbonate

205-633-8

144-55-8

Oxalic acid

205-634-3

144-62-7

Quinolin-8-ol

205-711-1

148-24-3

Thiabendazole

205-725-8

148-79-8

Benzothiazole-2-thiol

205-736-8

149-30-4

Monuron

205-766-1

150-68-5

Rutoside

205-814-1

153-18-4

Glyoxylic acid

206-058-5

298-12-4

Fenchlorphos

206-082-6

299-84-3

Naled

206-098-3

300-76-5

5-chlorosalicylic acid

206-283-9

321-14-2

Diuron

206-354-4

330-54-1

Potassium thiocyanate

206-370-1

333-20-0

Diazinon

206-373-8

333-41-5

Decanoic acid

206-376-4

334-48-5

Cyanamide

206-992-3

420-04-2

Metronidazole

207-136-1

443-48-1

Cineole

207-431-5

470-82-6

7,8-dihydroxycoumarin

207-632-8

486-35-1

Sodium carbonate

207-838-8

497-19-8

2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one

207-880-7

499-44-5

Carvacrol

207-889-6

499-75-2

6.beta.-acetoxy-3beta-(beta.-D-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide/Scilliroside

208-077-4

507-60-8

Barium carbonate

208-167-3

513-77-9

3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione

208-293-9

520-45-6

Osalmid

208-385-9

526-18-1

2,6-Dimethoxy-p-benzoquinone

208-484-7

530-55-2

Acridine-3,6-diamine dihydrochloride

208-515-4

531-73-7

Sodium benzoate

208-534-8

532-32-1

Dazomet

208-576-7

533-74-4

Trisodium hydrogendicarbonate/Sodium sesquicarbonate

208-580-9

533-96-0

Silver carbonate

208-590-3

534-16-7

Crimidine

208-622-6

535-89-7

Calcium diformate

208-863-7

544-17-2

Myristic acid

208-875-2

544-63-8

1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one

208-912-2

546-80-5

1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione/Hypericum perforatum

208-941-0

548-04-9

[4-[4,4′-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride

208-953-6

548-62-9

Zinc dibenzoate

209-047-3

553-72-0

Methyl isothiocyanate

209-132-5

556-61-6

4,4′-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride

209-321-2

569-61-9

[4-[alpha-[4-(dimethylamino)phenyl]benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride/Malachite green chloride

209-322-8

569-64-2

Potassium benzoate

209-481-3

582-25-2

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (all isomers; ratio: 1:1:1:1:1:1:1:1)/Allethrin

209-542-4

584-79-2

Sodium 3-(p-anilinophenylazo)benzenesulphonate/Metanil yellow

209-608-2

587-98-4

DL-lactic acid

209-954-4

598-82-3

BHC or HCH/Hexachlorocyclohexane

210-168-9

608-73-1

DL-malic acid

210-514-9

617-48-1

N-(hydroxymethyl)acetamide

210-897-2

625-51-4

Succinaldehyde

211-333-8

638-37-9

2-fluoroacetamide

211-363-1

640-19-7

Phthalaldehyde

211-402-2

643-79-8

2-hydroxyethanesulphonic acid, compound with 4,4′-[hexane-1,6-diylbis(oxy)]bis[benzenecarboxamidine] (2:1)

211-533-5

659-40-5

Tetrahydro-2,5-dimethoxyfuran

211-797-1

696-59-3

N-[(dichlorofluoromethyl)thio]phthalimide

211-952-3

719-96-0

Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid

211-986-9

731-27-1

Levonorgestrel

212-349-8

797-63-7

Hydroxyl-2-pyridone

212-506-0

822-89-9

2,6-dimethyl-1,3-dioxan-4-yl acetate

212-579-9

828-00-2

Terbutryn

212-950-5

886-50-0

Proflavine hydrochloride

213-459-9

952-23-8

N′1-quinoxalin-2-ylsulphanilamide, sodium salt

213-526-2

967-80-6

Norbormide

213-589-6

991-42-4

(hydroxymethyl)urea

213-674-8

1000-82-4

Dichlofluanid

214-118-7

1085-98-9

Copper thiocyanate

214-183-1

1111-67-7

Dodecyltrimethylammonium bromide

214-290-3

1119-94-4

Tetradonium bromide

214-291-9

1119-97-7

(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-Tetramethrin

214-619-0

1166-46-7

4,5-dichloro-3H-1,2-dithiol-3-one

214-754-5

1192-52-5

Xylenol

215-089-3

1300-71-6

Bentonite

215-108-5

1302-78-9

Diarsenic pentaoxide

215-116-9

1303-28-2

Diboron trioxide

215-125-8

1303-86-2

Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked lime

215-137-3

1305-62-0

Calcium oxide/lime/burnt lime/quicklime

215-138-9

1305-78-8

Potassium hydroxide

215-181-3

1310-58-3

Sodium hydroxide

215-185-5

1310-73-2

Silicic acid, potassium salt/Potassium silicate

215-199-1

1312-76-1

Zinc oxide

215-222-5

1314-13-2

Trizinc diphosphide

215-244-5

1314-84-7

Zinc sulphide

215-251-3

1314-98-3

Trimanganese tetraoxide

215-266-5

1317-35-7

Copper oxide

215-269-1

1317-38-0

Dicopper oxide

215-270-7

1317-39-1

Cresol

215-293-2

1319-77-3

Aluminum chloride, basic

215-477-2

1327-41-9

Disodium tetraborate, anhydrous

215-540-4

1330-43-4

Disodium tetraborate decahydrate

215-540-4

1303-96-4

Dicopper chloride trihydroxide

215-572-9

1332-65-6

Chromium trioxide

215-607-8

1333-82-0

Sodium hydrogendifluoride

215-608-3

1333-83-1

Naphthenic acids, copper salts

215-657-0

1338-02-9

2-Butanone, peroxide

215-661-2

1338-23-4

Naphthenic acids

215-662-8

1338-24-5

Ammonium hydrogendifluoride

215-676-4

1341-49-7

Silicic acid, sodium salt

215-687-4

1344-09-8

Copper(II) chloride

215-704-5

1344-67-8

N,N″-bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride

216-994-6

1715-30-6

Monolinuron

217-129-5

1746-81-2

2,4-dichlorobenzyl alcohol

217-210-5

1777-82-8

Ethacridine lactate

217-408-1

1837-57-6

4,4′-(2-ethyl-2-nitropropane-1,3-diyl)bismorpholine

217-450-0

1854-23-5

Chlorothalonil

217-588-1

1897-45-6

Dodecylammonium acetate

217-956-1

2016-56-0

Fluometuron

218-500-4

2164-17-2

Allyl propyl disulphide

218-550-7

2179-59-1

4-(2-nitrobutyl)morpholine

218-748-3

2224-44-4

N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine

219-145-8

2372-82-9

Didecyldimethylammonium bromide

219-234-1

2390-68-3

Tolnaftate

219-266-6

2398-96-1

Bis[[4-[4-(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium] oxalate, dioxalate

219-441-7

2437-29-8

Dodine

219-459-5

2439-10-3

2-bromo-1-(4-hydroxyphenyl)ethan-1-one

219-655-0

2491-38-5

2,2′-dithiobis[N-methylbenzamide]

219-768-5

2527-58-4

2,2′-[methylenebis(oxy)]bisethanol

219-891-4

2565-36-8

Phenthoate

219-997-0

2597-03-7

1,2-benzisothiazol-3(2H)-one

220-120-9

2634-33-5

2,2′-[(1-methylpropane-1,3-diyl)bis(oxy)]bis[4-methyl-1,3,2-dioxaborinane]

220-198-4

2665-13-6

2-methyl-2H-isothiazol-3-one

220-239-6

2682-20-4

Sulphuryl difluoride

220-281-5

2699-79-8

2-Amino-3-chloro-1,4-naphthoquinone

220-529-2

2797-51-5

2-chloro-N-(hydroxymethyl)acetamide

220-598-9

2832-19-1

Troclosene sodium

220-767-7

2893-78-9

Sodium dichloroisocyanurate dihydrate

220-767-7

51580-86-0

Chlorpyrifos

220-864-4

2921-88-2

Mecetronium ethyl sulphate

221-106-5

3006-10-8

Dodecylethyldimethylammonium ethyl sulphate

221-108-6

3006-13-1

Bis(trichloromethyl) sulphone

221-310-4

3064-70-8

Sodium 2-(2-dodecyloxyethoxy)ethyl sulphate

221-416-0

3088-31-1

4-isopropyl-m-cresol

221-761-7

3228-02-2

Copper dinitrate

221-838-5

3251-23-8

Triclosan

222-182-2

3380-34-5

Temephos

222-191-1

3383-96-8

Thuj-4(10)-ene

222-212-4

3387-41-5

Oct-1-ene-3-ol

222-226-0

3391-86-4

Sodium 5-chloro-2-[4-chloro-2-[[[(3,4-dichlorophenyl)amino]carbonyl]amino]phenoxy]benzenesulphonate

222-654-8

3567-25-7

(ethylenedioxy)dimethanol

222-720-6

3586-55-8

Chlorophacinone

223-003-0

3691-35-8

Dipyrithione

223-024-5

3696-28-4

Chlorhexidine dihydrochloride

223-026-6

3697-42-5

Denatonium benzoate

223-095-2

3734-33-6

Sodium 2,4,6-trichlorophenolate

223-246-2

3784-03-0

Pyridine-2-thiol 1-oxide, sodium salt

223-296-5

3811-73-2

Hexahydro-1,3,5-tris(3-methoxypropyl)-1,3,5-triazine

223-563-6

3960-05-2

4-oxo-4-[(tributylstannyl)oxy]but-2-enoic acid/Tributyltin maleate

223-701-5

4027-18-3

Methenamine 3-chloroallylochloride

223-805-0

4080-31-3

N-ethylheptadecafluorooctanesulphonamide

223-980-3

4151-50-2

Isobutyl 4-hydroxybenzoate/Isobutyl parabene

224-208-8

4247-02-3

Tributylstannyl salicylate/Tributyltin salicylate

224-397-7

4342-30-7

Tributylstannyl benzoate/Tributyltin benzoate

224-399-8

4342-36-3

Sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethanolate

224-580-1

4418-26-2

Diethylammonium salicylate

224-586-4

4419-92-5

Dimethyl dicarbonate

224-859-8

4525-33-1

Farnesol

225-004-1

4602-84-0

2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol

225-208-0

4719-04-4

Octylphosphonic acid

225-218-5

4724-48-5

Sodium 4-(methoxycarbonyl)phenolate

225-714-1

5026-62-0

Sulphamidic acid

226-218-8

5329-14-6

Citral

226-394-6

5392-40-5

Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione

226-408-0

5395-50-6

1-benzyl-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane chloride

226-445-2

5400-93-1

Dimethyldioctylammonium chloride

226-901-0

5538-94-3

N-dodecylpropane-1,3-diamine

226-902-6

5538-95-4

Chlorpyrifos-methyl

227-011-5

5598-13-0

N,N′-methylenebismorpholine

227-062-3

5625-90-1

Coumatetralyl

227-424-0

5836-29-3

Terbuthylazine

227-637-9

5915-41-3

(R)-p-mentha-1,8-diene

227-813-5

5989-27-5

4-methoxybenzene-1,3-diamine sulphate

228-290-6

6219-67-6

Methylene dithiocyanate

228-652-3

6317-18-6

1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione

229-222-8

6440-58-0

Dodicin

229-930-7

6843-97-6

Malic acid

230-022-8

6915-15-7

(2-bromo-2-nitrovinyl)benzene

230-515-8

7166-19-0

Didecyldimethylammonium chloride

230-525-2

7173-51-5

(Z)-N-9-octadecenylpropane-1,3-diamine

230-528-9

7173-62-8

Benzyldodecyldimethylammonium bromide

230-698-4

7281-04-1

Prometryn

230-711-3

7287-19-6

Silver

231-131-3

7440-22-4

Boron

231-151-2

7440-42-8

Copper

231-159-6

7440-50-8

Zinc

231-175-3

7440-66-6

Sulphur dioxide

231-195-2

7446-09-5

Dithallium sulphate

231-201-3

7446-18-6

Calcium dihexa-2,4-dienoate

231-321-6

7492-55-9

Quinine monohydrochloride dihydrate

231-437-7

6119-47-7

Iodine

231-442-4

7553-56-2

Iodine in the form of iodophor

Mixture

39392-86-4

Iodine complex in solution with non-ionic detergents

Mixture

 

Polyvinylpyrrolidone iodine

Polymer

25655-41-8

Alkylaryl polyether alcohol-iodine complex

Polymer

 

Iodine complex with ethylene-propylene block co-Polymer (pluronic)

Polymer

 

Iodine complex with poly alkylenglycol

Polymer

 

Iodinated Resin/Polyiodide Anion Resin

Polymer

 

Trisodium orthophosphate (TSP)

231-509-8

7601-54-9

Silicon dioxide — amorphous

231-545-4

7631-86-9

Sodium hydrogensulphite

231-548-0

7631-90-5

Sodium nitrite

231-555-9

7632-00-0

Sodium peroxometaborate/Sodium perborate hydrate

231-556-4

7632-04-4

Hydrogen chloride/Hydrochloric acid

231-595-7

7647-01-0

Sodium chloride

231-598-3

7647-14-5

Sodium bromide

231-599-9

7647-15-6

Orthophosphoric acid

231-633-2

7664-38-2

Hydrogen fluoride

231-634-8

7664-39-3

Ammonia, anhydrous

231-635-3

7664-41-7

Sulphuric acid

231-639-5

7664-93-9

Potassium iodide

231-659-4

7681-11-0

Sodium hydrogensulphate

231-665-7

7681-38-1

Sodium fluoride

231-667-8

7681-49-4

Sodium hypochlorite

231-668-3

7681-52-9

Disodium disulphite

231-673-0

7681-57-4

Tetramethrin

231-711-6

7696-12-0

Sulphur

231-722-6

7704-34-9

Iron sulphate

231-753-5

7720-78-7

Iron vitriol/Ferrous sulphate heptahydrate/Iron sulphate heptahydrate

231-753-5

7782-63-0

Potassium permanganate

231-760-3

7722-64-7

Hydrogen peroxide

231-765-0

7722-84-1

Bromine

231-778-1

7726-95-6

Dipotassium peroxodisulphate

231-781-8

7727-21-1

Nitrogen

231-783-9

7727-37-9

Zinc sulphate heptahydrate

231-793-3

7446-20-0

7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole

231-810-4

7747-35-5

Sodium sulphite

231-821-4

7757-83-7

Sodium chlorite

231-836-6

7758-19-2

Copper chloride

231-842-9

7758-89-6

Copper sulphate

231-847-6

7758-98-7

Copper sulphate pentahydrate

231-847-6

7758-99-8

Silver nitrate

231-853-9

7761-88-8

Sodium thiosulphate pentahydrate

231-867-5

10102-17-7

Sodium chlorate

231-887-4

7775-09-9

Disodium peroxodisulphate/Sodium persulphate

231-892-1

7775-27-1

Potassium dichromate

231-906-6

7778-50-9

Calcium hypochlorite

231-908-7

7778-54-3

Hexahydro-1,3,5-triethyl-1,3,5-triazine

231-924-4

7779-27-3

Chlorine

231-959-5

7782-50-5

Ammonium sulphate

231-984-1

7783-20-2

Silver chloride

232-033-3

7783-90-6

Aluminium ammonium bis(sulphate)

232-055-3

7784-25-0

Manganese sulphate

232-089-9

7785-87-7

Manganese sulphate tetrahydrate

232-089-9

10101-68-5

Iodine monochloride

232-236-7

7790-99-0

Terpineol

232-268-1

8000-41-7

Soybean oil

232-274-4

8001-22-7

Linseed oil

232-278-6

8001-26-1

Corn oil

232-281-2

8001-30-7

Coconut oil

232-282-8

8001-31-8

Creosote

232-287-5

8001-58-9

Castor oil

232-293-8

8001-79-4

Bone oil/Animal oil

232-294-3

8001-85-2

Rape oil

232-299-0

8002-13-9

Pyrethrins and Pyrethroids

232-319-8

8003-34-7

Terpinol

8006-39-1

Turpentine oil

232-350-7

8006-64-2

Garlic ext.

232-371-1

8008-99-9

Tar, pine/Pine wood tar

232-374-8

8011-48-1

Beeswax

232-383-7

8012-89-3

Paraffin oils

232-384-2

8012-95-1

Oils, avocado

232-428-0

8024-32-6

Orange, sweet, ext.

232-433-8

8028-48-6

White mineral oil (petroleum)

232-455-8

8042-47-5

Saponins

232-462-6

8047-15-2

Tall-oil rosin

232-484-6

8052-10-6

Asphalt/Bitumen

232-490-9

8052-42-4

Copals

232-527-9

9000-14-0

Lignin

232-682-2

9005-53-2

Aluminium sulphate

233-135-0

10043-01-3

Boric acid

233-139-2

10043-35-3

Aluminium potassium bis(sulphate)/Alum

233-141-3

10043-67-1

Chlorine dioxide

233-162-8

10049-04-4

Potassium sulphite

233-321-1

10117-38-1

Sodium hydrogen 2,2′methylenebis[4-chlorophenolate]

233-457-1

10187-52-7

2,2-dibromo-2-cyanoacetamide

233-539-7

10222-01-2

Disilver(1+) sulphate

233-653-7

10294-26-5

Sodium metaphosphate

233-782-9

10361-03-2

Oxine-copper

233-841-9

10380-28-6

Resmethrin

233-940-7

10453-86-8

N,N′-ethylenebis[N-acetylacetamide]

234-123-8

10543-57-4

Sodium dichromate

234-190-3

10588-01-9

Carbendazim

234-232-0

10605-21-7

Tridecasodium hypochloritetetrakis(phosphate)

234-307-8

11084-85-8

Natural boric acid

234-343-4

11113-50-1

Sodium perborate tetrahydrate

234-390-0

10486-00-7

Perboric acid, sodium salt

234-390-0

11138-47-9

Naphthenic acids, zinc salts

234-409-2

12001-85-3

Disodium octaborate

234-541-0

12008-41-2

Disodium octaborate tetrahydrate

234-541-0

12280-03-4

[2H4]ammonium chloride

234-607-9

12015-14-4

Dialuminium chloride pentahydroxide

234-933-1

12042-91-0

Trimagnesium diphosphide

235-023-7

12057-74-8

Sodium toluenesulphonate

235-088-1

12068-03-0

Copper(II) carbonate-copper(II) hydroxide (1:1)

235-113-6

12069-69-1

Zineb

235-180-1

12122-67-7

Ammonium bromide

235-183-8

12124-97-9

Tetraboron disodium heptaoxide, hydrate

235-541-3

12267-73-1

Maneb

235-654-8

12427-38-2

Hexaboron dizinc undecaoxide/Zinc borate

235-804-2

12767-90-7

N-(hydroxymethyl)formamide

235-938-1

13052-19-2

2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine

236-035-5

13108-52-6

Nifurpirinol

236-503-9

13411-16-0

Pyrithione zinc

236-671-3

13463-41-7

Titanium dioxide

236-675-5

13463-67-7

Dodecylguanidine monohydrochloride

237-030-0

13590-97-1

Barium diboron tetraoxide

237-222-4

13701-59-2

Potassium 2-biphenylate

237-243-9

13707-65-8

Ammonium tetrafluoroborate

237-531-4

13826-83-0

Lithium hypochlorite

237-558-1

13840-33-0

Orthoboric acid, sodium salt

237-560-2

13840-56-7

Bromine chloride

237-601-4

13863-41-7

Zinc bis(diethyldithiocarbamate)

238-270-9

14324-55-1

(benzyloxy)methanol

238-588-8

14548-60-8

2,2′-oxybis[4,4,6-trimethyl-1,3,2-dioxaborinane]

238-749-2

14697-50-8

Phoxim

238-887-3

14816-18-3

Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper

238-984-0

14915-37-8

Bis(8-hydroxyquinolyl) sulphate, monopotassium salt

239-133-6

15077-57-3

Dibromopropionamide

239-153-5

15102-42-8

Sodium perborate monohydrate

239-172-9

10332-33-9

2,2′-methylenebis(6-bromo-4-chlorophenol)

239-446-8

15435-29-7

Chlorotoluron

239-592-2

15545-48-9

Disodium carbonate, compound with hydrogen peroxide (2:3)

239-707-6

15630-89-4

Sodium p-chloro-m-cresolate

239-825-8

15733-22-9

Chloralose

240-016-7

15879-93-3

1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione

240-230-0

16079-88-2

(R)-2-(4-chloro-2-methylphenoxy)propionic acid

240-539-0

16484-77-8

Dipotassium disulphite

240-795-3

16731-55-8

Methomyl

240-815-0

16752-77-5

Disodium hexafluorosilicate

240-934-8

16893-85-9

Hexafluorosilicic acid

241-034-8

16961-83-4

Benomyl

241-775-7

17804-35-2

D-gluconic acid, compound with N,N″-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1)

242-354-0

18472-51-0

O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate

242-624-8

18854-01-8

Benzoxonium chloride

243-008-1

19379-90-9

Methyl hydroxymethoxyacetate

243-271-2

19757-97-2

p-[(diiodomethyl)sulphonyl]toluene

243-468-3

20018-09-1

Copper dihydroxide

243-815-9

20427-59-2

Disilver oxide

243-957-1

20667-12-3

2-butene-1,4-diyl bis(bromoacetate)

243-962-9

20679-58-7

Aluminium phosphide

244-088-0

20859-73-8

(benzothiazol-2-ylthio)methyl thiocyanate

244-445-0

21564-17-0

Tetrachlorvinphos

244-865-4

22248-79-9

Bendiocarb

245-216-8

22781-23-3

2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Prallethrin

245-387-9

23031-36-9

Potassium (E,E)-hexa-2,4-dienoate

246-376-1

24634-61-5

2-tert-Butyl-4-methoxyphenol

246-563-8

25013-16-5

Bis(hydroxymethyl)urea

246-679-9

25155-29-7

.alpha.,.alpha.′,.alpha.″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol

246-764-0

25254-50-6

2,2′-(octadec-9-enylimino)bisethanol

246-807-3

25307-17-9

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Cinerin I

246-948-0

25402-06-6

3-phenoxybenzyl 2-dimethyl-3-(methylpropenyl)cyclopropanecarboxylate/Phenothrin

247-404-5

26002-80-2

5-chloro-2-methyl-2H-isothiazol-3-one

247-500-7

26172-55-4

2-octyl-2H-isothiazol-3-one

247-761-7

26530-20-1

Dodecylbenzenesulphonic acid

248-289-4

27176-87-0

Lauric acid, monoester with glycerol

248-337-4

27215-38-9

Zinc neodecanoate

248-370-4

27253-29-8

Dodecyl(ethylbenzyl)dimethylammonium chloride

248-486-5

27479-28-3

Cis-tricos-9-ene

248-505-7

27519-02-4

Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride

248-595-8

27668-52-6

N′-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine

248-872-3

28159-98-0

(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (only 1R trans, 1S isomer)/S-Bioallethrin

249-013-5

28434-00-6

Bioresmethrin

249-014-0

28434-01-7

3-[3-(4′-bromo[1,1′-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2-benzopyrone/Bromadiolone

249-205-9

28772-56-7

Pirimiphos-methyl

249-528-5

29232-93-7

Lithium heptadecafluorooctanesulphonate

249-644-6

29457-72-5

5-bromo-5-nitro-1,3-dioxane

250-001-7

30007-47-7

Trans-isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]crotonate

250-517-2

31218-83-4

(Z,E)-tetradeca-9,12-dienyl acetate

250-753-6

30507-70-1 (1)

Decyldimethyloctylammonium chloride

251-035-5

32426-11-2

Bromochloro-5,5-dimethylimidazolidine-2,4-dione

251-171-5

32718-18-6

Amitraz

251-375-4

33089-61-1

3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon

251-835-4

34123-59-6

2-(hydroxymethylamino)ethanol

251-974-0

34375-28-5

N-[3-(dodecylamino)propyl]glycine

251-993-4

34395-72-7

2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3(2H,9bH)-dione, monosodium salt

252-204-6

34769-44-3

Sodium 4-ethoxycarbonylphenoxide

252-487-6

35285-68-8

Sodium 4-propoxycarbonylphenoxide

252-488-1

35285-69-9

N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide

252-529-3

35367-38-5

1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole/Imazalil

252-615-0

35554-44-0

(±)-1-(.beta.-allyloxy-2,4-dichlorophenylethyl)imidazole/Technical grade imazalil

Plant protection product

73790-28-0

S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate/Azamethiphos

252-626-0

35575-96-3

2-bromo-2-(bromomethyl)pentanedinitrile

252-681-0

35691-65-7

Benzyldimethyloleylammonium chloride

253-363-4

37139-99-4

Calcium magnesium oxide/dolomitic lime

253-425-0

37247-91-9

Calcium magnesium tetrahydroxide/calcium magnesium hydroxide/hydrated dolomitic lime

254-454-1

39445-23-3

2-phosphonobutane-1,2,4-tricarboxylic acid

253-733-5

37971-36-1

4-methoxy-m-phenylenediammonium sulphate

254-323-9

39156-41-7

N,N″-methylenebis[N′-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]

254-372-6

39236-46-9

Dinocap

254-408-0

39300-45-3

alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate

254-484-5

39515-40-7

Isopropyl (2E,4E)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate/Methoprene

254-993-2

40596-69-8

Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride

255-451-8

41591-87-1

Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol

255-953-7

42822-86-6

4,4-dimethyloxazolidine

257-048-2

51200-87-4

(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-cis)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate

257-144-4

51348-90-4

Cyano (3-phenoxybenzyl)-2-(4-chlorophenyl)-3-methylbutyrate/Fenvalerate

257-326-3

51630-58-1

ethyl N-acetyl-N-butyl-.beta.-alaninate

257-835-0

52304-36-6

.alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cypermethrin

257-842-9

52315-07-8

m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Permethrin

258-067-9

52645-53-1

.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate/Deltamethrin

258-256-6

52918-63-5

bis(2-ethylhexanoato-O)-.mu.-oxodizinc

259-049-3

54262-78-1

1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Empenthrin

259-154-4

54406-48-3

3-iodo-2-propynyl butylcarbamate

259-627-5

55406-53-6

Tetrakis(hydroxymethyl)phosphonium sulphate(2:1)

259-709-0

55566-30-8

3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin/Difenacoum

259-978-4

56073-07-5

4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin/Brodifacoum

259-980-5

56073-10-0

[2-(2-butoxyethoxy)ethoxy]methanol

260-097-2

56289-76-0

2-ethoxyethyl bromoacetate

260-240-9

56521-73-4

N-octyl-N′-[2-(octylamino)ethyl]ethylenediamine

260-725-5

57413-95-3

1,2-benzisothiazol-3(2H)-one, sodium salt

261-184-8

58249-25-5

Azaconazole

262-102-3

60207-31-0

1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/Propiconazole

262-104-4

60207-90-1

N,N-bis(2-hydroxyethyl)undec-10-enamide

262-114-9

60239-68-1

2-chloro-3-(phenylsulphonyl)acrylonitrile

262-395-8

60736-58-5

Tetradecyldimethylbenzylammonium fluoride

61134-95-0

[1,1′-Biphenyl]-2-ol, chlorinated

262-974-5

61788-42-9

Amines, coco alkyl

262-977-1

61788-46-3

Quaternary ammonium compounds, (hydrogenated tallow alkyl)trimethyl, chlorides

263-005-9

61788-78-1

Quaternary ammonium compounds, coco alkyltrimethyl, chlorides

263-038-9

61789-18-2

Quaternary ammonium compounds, benzylcoco alkylbis(hydroxyethyl), chlorides

263-078-7

61789-68-2

Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides

263-080-8

61789-71-7

Quaternary ammonium compounds, dicocoalkyl dimethyl, chlorides

263-087-6

61789-77-3

Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides

263-090-2

61789-80-8

Quaternary ammonium compounds, trimethylsoya alkyl, chlorides

263-134-0

61790-41-8

Ethanol, 2,2′-iminobis-, N-coco alkyl derivs.

263-163-9

61791-31-9

1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortall-oil alkyl derivs.

263-171-2

61791-39-7

Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl, chlorides

263-185-9

61791-52-4

Amines, N-tallow alkyldipropylenetri-

263-191-1

61791-57-9

Amines, N-coco alkyltrimethylenedi-

263-195-3

61791-63-7

Amines, N-coco alkyltrimethylenedi-, acetates

263-196-9

61791-64-8

Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides

264-151-6

63449-41-2

4,5-dichloro-2-octyl-2H-isothiazol-3-one

264-843-8

64359-81-5

2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide

264-980-3

64628-44-0

Distillates (petroleum), solvent-refined light naphthenic

265-098-1

64741-97-5

Distillates (petroleum), hydrotreated light

265-149-8

64742-47-8

N-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-6-hydroxy-1,3-dimethyl-2,4-dioxopyrimidine-5-carboxamide

265-732-7

65400-98-8

.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate

265-898-0

65731-84-2

Tar acids, coal, crude

266-019-3

65996-85-2

Glass powder

266-046-0

65997-17-3

3,3′-methylenebis[5-methyloxazolidine]/Oxazolidin

266-235-8

66204-44-2

N-cyclopropyl-1,3,5-triazine-2,4,6-triamine

266-257-8

66215-27-8

Betaines, C12-C14-alkyl dimethyl

266-368-1

66455-29-6

.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(1,2,2,2-tetrabromoethyl)cyclopropanecarboxylate/Tralomethrin

266-493-1

66841-25-6

2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide

266-583-0

67129-08-2

Cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine

266-719-9

67564-91-4

N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide

266-994-5

67747-09-5

Fatty acids, C16-18 and C18-unsatd., Me esters

267-015-4

67762-38-3

.alpha-cyano-3-phenoxybenzyl 3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethyl cyclopropanecarboxylate/Cyhalothrin

268-450-2

68085-85-8

Dodecylethyldimethylammonium bromide/Laudacit

269-249-2

68207-00-1

Shale oils

269-646-0

68308-34-9

.alpha.-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cyfluthrin

269-855-7

68359-37-5

Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides

269-919-4

68391-01-5

Quaternary ammonium compounds, di-C6-12-alkyldimethyl, chlorides

269-925-7

68391-06-0

Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts

270-115-0

68411-30-3

Quaternary ammonium compounds, benzyl-C8-16-alkyldimethyl, chlorides

270-324-7

68424-84-0

Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides

270-325-2

68424-85-1

Betaines, coco alkyldimethyl

270-329-4

68424-94-2

Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides

270-331-5

68424-95-3

Fatty acids, coco, reaction products with diethanolamine

270-430-3

68440-04-0

1-Propanaminium, 3-amino-N,N,N-trimethyl-, N-C12-18 acyl derivs., Me sulfates

271-063-1

68514-93-2

Amides, coco, N,N-bis(2-hydroxyethyl)

271-657-0

68603-42-9

Quaternary ammonium compounds, (oxydi-2,1-ethanediyl)bis[coco alkyldimethyl, dichlorides

271-761-6

68607-28-3

9-Octadecenoic acid (Z)-, sulfonated, potassium salts

271-843-1

68609-93-8

Urea, reaction products with formaldehyde

271-898-1

68611-64-3

Imidazolium compounds, 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-norcoco alkyl, hydroxides, sodium salts

272-043-5

68650-39-5

bis(tetraamminecopper) carbonatedihydroxide

272-415-7

68833-88-5

1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)

272-574-2

68890-66-4

Amines, N-tallowalkyl trimethylenedi-, diacetates

272-786-5

68911-78-4

Quassia, ext.

272-809-9

68915-32-2

Fatty acids, C8-10

273-086-2

68937-75-7

Sulfuric acid, mono-C12-18-alkyl esters, sodium salts

273-257-1

68955-19-1

Quaternary ammonium compounds, C12-18-alkyl[(ethylphenyl)methyl]dimethyl, chlorides

273-318-2

68956-79-6

Didecylmethyl[3-(trimethoxysilyl)propyl]ammonium chloride

273-403-4

68959-20-6

Quaternary ammonium compounds, benzyl-C10-16-alkyldimethyl, chlorides

273-544-1

68989-00-4

Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1)

273-545-7

68989-01-5

Sodium N-(hydroxymethyl)glycinate

274-357-8

70161-44-3

Amines, C10-16-alkyldimethyl, N-oxides

274-687-2

70592-80-2

Pentapotassium bis(peroxymonosulphate) bis(sulphate)

274-778-7

70693-62-8

N,N′-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride

274-861-8

70775-75-6

1,3-didecyl-2-methyl-1H-imidazolium chloride

274-948-0

70862-65-6

ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate/Fenoxycarb

276-696-7

72490-01-8

Quaternary ammonium compounds, di-C8-18-alkyldimethyl, chlorides

277-453-8

73398-64-8

1-[(hydroxymethyl)amino]propan-2-ol

278-534-0

76733-35-2

1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea/Diazolidinylurea

278-928-2

78491-02-8

Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-)

279-013-0

78948-87-5

Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) hexahydrate

279-013-0

114915-85-4

Tributyltetradecylphosphonium chloride

279-808-2

81741-28-8

(2-Butoxyethoxy)methanol

281-648-3

84000-92-0

Zinc, isodecanoate isononanoate complexes, basic

282-786-7

84418-73-5

Juniper, Juniperus communis, ext.

283-268-3

84603-69-0

Laurus nobilis, ext.

283-272-5

84603-73-6

Rosemary, ext.

283-291-9

84604-14-8

Eucalyptus globulus, ext.

283-406-2

84625-32-1

Cinnamomum zeylanicum, ext.

283-479-0

84649-98-9

Margosa ext.

283-644-7

84696-25-3

Lavender, Lavandula angustifolia angustifolia, ext.

283-994-0

84776-65-8

Thyme, Thymus serpyllum, ext.

284-023-3

84776-98-7

Formaldehyde, reaction products with diethylene glycol

284-062-6

84777-35-5

Formamide, reaction products with formaldehyde

284-064-7

84777-37-7

Glycine, N-(3-aminopropyl)-, N′-C10-16-alkyl derivs.

284-065-2

84777-38-8

Lemon, ext.

284-515-8

84929-31-7

Thyme, Thymus vulgaris, ext.

284-535-7

84929-51-1

Clove, ext.

284-638-7

84961-50-2

Tar acids, polyalkylphenol fraction

284-893-4

84989-05-9

Melaleuca alternifolia, ext./Australian Tea Tree Oil

285-377-1

85085-48-9

2,4,8,10-tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d,g][1,3,2]dioxaphosphocin 6-oxide, sodium salt

286-344-4

85209-91-2

Formaldehyde, reaction products with propylene glycol

286-695-3

85338-22-3

Stannane, tributyl-, mono(naphthenoyloxy) derivs.

287-083-9

85409-17-2

Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides

287-089-1

85409-22-9

Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides

287-090-7

85409-23-0

[R-(Z)]-3-[(12-hydroxy-1-oxo-9-octadecenyl)amino]propyltrimethylammonium methyl sulphate

287-462-9

85508-38-9

Benzenesulfonic acid, 4-C10-13-sec-alkyl derives.

287-494-3

85536-14-7

Guanidine, N,N‴-1,3-propanediylbis-, N-coco alkyl derivs., diacetates

288-198-7

85681-60-3

Sulfonic acids, C13-17-sec-alkane, sodium salts

288-330-3

85711-69-9

.alpha.-cyano-4-fluoro-3-phenoxybenzyl [1.alpha.(S*),3.alpha.]-(±)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate

289-244-9

86560-93-2

Chrysanthemum cinerariaefolium, ext.

289-699-3

89997-63-7

Cymbopogon nardus, ext.

289-753-6

89998-15-2

Lavender, Lavandula angustifolia, ext.

289-995-2

90063-37-9

Litsea cubeba, ext.

290-018-7

90063-59-5

Mentha arvensis, ext.

290-058-5

90063-97-1

Pelargonium graveolens, ext.

290-140-0

90082-51-2

Benzenesulfonic acid, mono-C10-14-alkyl derivs., compds. with Me 1H-benzimidazol-2-ylcarbamate

290-651-9

90194-41-5

Copper, EDTA-complexes

290-989-7

90294-99-8

Formaldehyde, reaction products with propanolamine

291-325-9

90387-52-3

Urea, N,N′-bis(hydroxymethyl)-, reaction products with 2-(2-butoxyethoxy)ethanol, ethylene glycol and formaldehyde

292-348-7

90604-54-9

Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, bromides

293-522-5

91080-29-4

Fir, Abies sibirica, ext.

294-351-9

91697-89-1

Juniper, Juniperus mexicana, ext.

294-461-7

91722-61-1

Lavender, Lavandula hybrida, ext./Lavandin oil

294-470-6

91722-69-9

Amines, N-(3-aminopropyl)-N′-coco alkyltrimethylenedi-, monoacrylated

294-702-6

91745-32-3

Cymbopogon winterianus, ext.

294-954-7

91771-61-8

Lemongrass (Cymbopogon flexuosus)

295-161-9

91844-92-7

White mineral oil (petroleum), light

295-550-3

92062-35-6

N-[3-(dodecylamino)propyl]glycine hydrochloride

298-216-5

93778-80-4

Bis(2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3(2H,9bH)-dibenzofurandionato-O2,O3)copper

304-146-9

94246-73-8

Citrus, ext.

304-454-3

94266-47-4

Pine ext.

304-455-9

94266-48-5

Trimethyl-3-[(1-oxo-10-undecenyl)amino]propylammonium methyl sulphate

304-990-8

94313-91-4

Peppermint, American, ext.

308-770-2

98306-02-6

Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts

309-206-8

100085-64-1

Corn cob, powdered

310-127-6

999999-99-4

Natural lemon juice (filtered)

310-127-6

999999-99-4

Hedera helix

310-127-6

999999-99-4

Onion Oil

310-127-6

999999-99-4

Thuja occidentalis

310-127-6

999999-99-4

Salvia officinalis

310-127-6

999999-99-4

Hyssopus officinalis

310-127-6

999999-99-4

Chrysanthemum vulgare

310-127-6

999999-99-4

Artemisia absinthium

310-127-6

999999-99-4

Achillea millefolium

310-127-6

999999-99-4

Origanum vulgare

310-127-6

999999-99-4

Majorana hortensis

310-127-6

999999-99-4

Origanum majorano

310-127-6

999999-99-4

Rosmarinus officinalis

310-127-6

999999-99-4

Satureja hortensis

310-127-6

999999-99-4

Uritica dioica

310-127-6

999999-99-4

Aesculus hippocastanum

310-127-6

999999-99-4

Symphytum officinale

310-127-6

999999-99-4

Equisetum arvense

310-127-6

999999-99-4

Sambucus nigra

310-127-6

999999-99-4

1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea/Hexaflumuron

401-400-1

86479-06-3

1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione

401-570-7

89415-87-2

1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/Tebuconazole

403-640-2

107534-96-3

Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamine

403-950-8

164907-72-6

Mixture of: (C8-18)alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate;(C8-18)alkylbis(2-hydroxyethyl)ammonium 2-ethylhexylhydrogenphosphate

404-690-8

68132-19-4

(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane

405-020-7

105024-66-6

2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate/Transfluthrin

405-060-5

118712-89-3

5,5-dimethyl-perhydro-pyrimidin-2-one .alpha.-(4-trifluoromethylstyryl)-.alpha.-(4-trifluoromethyl)cinnamylidenehydrazone/Hydramethylnon

405-090-9

67485-29-4

3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether/Etofenprox

407-980-2

80844-07-1

6-(phthalimido)peroxyhexanoic acid

410-850-8

128275-31-0

Lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide

411-690-1

111337-53-2

Methyl neodecanamide

414-460-9

105726-67-8

Mixture of: alpha-cyano-3-phenoxybenzyl (Z)-(1R,3R)-[(S)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate;alpha-cyano-3-phenoxybenzyl (Z)-(1S,3S)-[(R)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate/Lambda cyhalothrin

415-130-7

91465-08-6

1-(4-(2-cloro-a,a,a-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea/Flufenoxuron

417-680-3

101463-69-8

2-butyl-benzo[d]isothiazol-3-one

420-590-7

04299-07-4

Tetrachlorodecaoxide complex

420-970-2

92047-76-2

Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin/Flocoumafen

421-960-0

90035-08-8

sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine

423-210-8

119515-38-7

N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide

423-990-1

149118-66-1

Fipronil

424-610-5

120068-37-3

cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride

426-020-3

51229-78-8

1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine/Imidacloprid

428-040-8

138261-41-3

Thiamethoxam

428-650-4

153719-23-4

[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate/Imiprothrin

428-790-6

72963-72-5

5-chloro-2-(4-chlorphenoxy)phenol

429-209-0

3380-30-1

2-(1-methyl-2-(4-phenoxy-phenoxy)-ethoxy)-pyridine/Pyriproxyfen

429-800-1

95737-68-1

3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide

431-030-6

163269-30-5

Reaction products of diisopropanolamine with formaldehyde(1:4)

432-440-8

220444-73-5

Chloromethyl n-octyl disulfide

432-680-3

180128-56-7

Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succinate with hydrogen peroxide/Perestane

432-790-1

 

Bis(3-aminopropyl)octylamine

433-340-7

86423-37-2

(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine

433-460-1

210880-92-5

(E)-2-Octadecenal

Not yet allocated

51534-37-3

(E,Z)-2,13-Octadecadienal

Not yet allocated

99577-57-8

Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containing

Not yet allocated

398477-47-9

Silver sodium hydrogen zirconium phosphate

Not yet allocated

 

Paraformaldehyde

 

30525-89-4

Peroxyoctanoic acid

 

33734-57-5

Bromomyristyl isoquinoline

 

51808-87-8

9-Aminoacridine hydrochloride monohydrate

 

52417-22-8

Chlorinated trisodium phosphate

 

56802-99-4

Cyclohexylhydroxydiazene 1-oxide, potassium salt

 

66603-10-9

(1S,2R,5S)-2-Isopropenyl-5-methylcyclohexanol

 

104870-56-6

Silica, amorphous, crystalline-free

 

112945-52-5

Denatonium Capsaicinate

 

192327-95-0

Tris(N-cyclohexyldiazeniumdioxy)aluminium

 

312600-88-7

Bis[1-cyclohexyl-1,2-di(hydroxy-.kappa.O)diazeniumato(2-)]-copper

 

312600-89-8

Reaction product of essential oils and ozone in-situ (Open Air Factor (OAF))

 

 

Silver zeolite A

 

 

Silver sodium borosilicate

 

 

5-Chloro-2-(4-chlorophenoxy)phenol

 

 

Benzyl-lauryl-dimethyl-myristylammonium chloride/Lauryl-myristyl dimethyl benzyl ammonium chloride

 

 

((1,2-Ethanediylbis(carbamodithioato))(2-))manganese mixture with ((1,2-ethandiylbis(carbamodithioate))(2-))zinc/Mancozeb

Plant protection product

8018-01-7

Chlorosulfamic acid

Plant protection product

17172-27-9

2-bromo-1-(2,4-dichlorophenyl)vinyl diethyl phosphate/bromfenvinfos

Plant protection product

33399-00-7

Ethyl (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoate/Hydroprene

Plant protection product

41096-46-2

Silicium dioxide/Kieselguhr

Plant protection product

61790-53-2

.alpha.,.alpha.,.alpha.-Trifluoro-N-methyl-4,6-dinitro-N-(2,4,6-tribromophenyl)-o-toluidine/Bromethalin

Plant protection product

63333-35-7

S-Methoprene/Isopropyl (s-(E,E))-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate

Plant protection product

65733-16-6

S-Hydroprene/Ethyl (S-(E,E))-3,7,11-trimethyldodeca-2,4-dienoate

Plant protection product

65733-18-8

Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate

Plant protection product

66230-04-4

[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2.2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/alpha-Cypermethrin

Plant protection product

67375-30-8

Abamectin (Mixture of Avermectin B1a; > 80 %, EINECS 265-610-3; and Avermectin B1b; < 20 % EINECS 265-611-9)

265-610-3

71751-41-2

Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2-methyl[1,1′-biphenyl]-3-ylmethyl ester, (1R,3R)-rel-/Bifenthrin/Biphenate

Plant protection product

82657-04-3

N-(2-((2,6-Dimethyl)phenyl)amino)-2-oxoethyl)-N,N-diethyl benzenemethanaminiumsaccharide/Denatonium Saccharide

Plant protection product

90823-38-4

.alpha.-(4-Chlorophenyl)-.alpha.-(1-cyclopropylethyl)-1H-1,2,4-triazole-1-ethanol/Cyproconazole

Plant protection product

94361-06-5

3-(3-(4′-Bromo-(1,1′-biphenyl)-4-yl)-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran-2-one/3-((RS,3RS;1RS,3SR)-3-(4′-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one/Difethialone

Plant protection product

104653-34-1

Guazatine triacetate

Plant protection product

115044-19-4

4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/Chlorfenapyr

Plant protection product

122453-73-0

Aluminium sodium silicate-silver complex/Silver zeolite

Plant protection product

130328-18-6

Aluminium sodium silicate-silver copper complex/Silver Copper Zeolite

Plant protection product

130328-19-7

Aluminium sodium silicate-silver zinc complex/Silver-Zinc-Zeolite

Plant protection Product

130328-20-0

N-Isononyl-N,N-dimethyl-N-decylammonium chloride

Plant protection product

138698-36-9

N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide/Acetamiprid

Plant protection product

160430-64-8

3-phenoxybenzyl (1R)-cis,trans-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Phenothrin

Plant protection product

188023-86-1

Mixture of 5-Hydroxymethoxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 59720-42-2, 16,0 %) and 5-Hydroxy-1-aza-3,7-dioxabicyclo(3.3.0)octane (EINECS 229-457-6, 28,8 %), and 5-Hydroxypoly[methyleneoxy]methyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 56709-13-8; 5,2 %) in water (50 %)

Plant protection product

 

[1.alpha.(S*),3.alpha.]-(.alpha.)-Cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dichlorovinyl)-2,2-dimenthylcyclopropanecarboxylate

Plant protection product

 

S-Cyphenothrin

Plant protection product

 

(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1RS only 1:1)/Bioallethrin/d-trans-Allethrin

Plant protection product

 

(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1)/d-Allethrin

Plant protection product

 

(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3)/Esbiothrin

Plant protection product

 

Spinosad: fermentation product of soil micro-organism containing Spinosyn A and Spinosyn D

Plant protection product

 

Butoxy polypropylene glycol

Polymer

9003-13-8

Polydimethylsiloxane

Polymer

9016-00-6

Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloromethyl)oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chloride

Polymer

25988-97-0

Polymer of N,N,N,N-tetramethyl-ethane-1,2-diamine and (chloromethyl)oxirane

Polymer

25988-98-1

Homopolymer of 2-tert-butylaminoethyl methacrylate (EINECS 223-228-4)

Polymer

26716-20-1

Polymer of formaldehyde and acrolein

Polymer

26781-23-7

Monohydro chloride of polymer of N,N‴-1,6-hexanediylbis[N′-cyanoguanidine] (EINECS 240-032-4) and hexamethylenediamine (EINECS 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride)

Polymer

27083-27-8/32289-58-0

Polymer of N,N,N′,N′-tetramethyl-1,6-hexanediamine and 1,6-dichlorohexane

Polymer

27789-57-7

Poly(hexamethylendimethylammonium chloride)/Poly[(dimethylimino)-1,6-hexanediyl-chloride]

Polymer

28728-61-2

N,N,N′,N′–Tetramethylethylenediaminebis(2-chloroethyl)ether copolymer

Polymer

31075-24-8

Poly(hexamethylendiamine guanidinium chloride)

Polymer

57028-96-3

Poly(hexamethylenebiguanide)

Polymer

91403-50-8

Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt)

Polymer

94667-33-1

N,N-Didecyl(-N-methyl-poly(oxyethyl)ammoniumpropionate/1-Decanaminium, N-decyl-N-(2-hydroxyethyl)-N-methyl-, propanoate (salt)

Polymer

107879-22-1

Copolymer of 2-propenal and propane-1,2-diol

Polymer

191546-07-3

N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate

Polymer

214710-34-6

Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride)

Polymer

374572-91-5

Tributyltin coPolymer (TBT-coPolymer)

Polymer

 

Fat alcohol polyglycol ether

Polymer

 

Poly(vinyl chloride-co-isobutyl vinyl ether-co-N-vinyl, N′-dimethyl octyl bromide propyl diamine)

Polymer

 

Polyglycolpolyamine resin

Polymer

 

Sodium lignosulfonate

Natural Polymer

8061-51-6

Neem/Neem-Vital

Natural oil

5945-86-8

Pinus pumilio oil

Natural oil

8000-26-8

Cedarwood oil

Natural oil

8000-27-9

Lavender oil

Natural oil

8000-28-0

Citronella oil

Natural oil

8000-29-1

Essential oil of eugenia caryophyllus

Natural oil

8000-34-8

Geranium oil

Natural oil

8000-46-2

Eucalyptus Oil

Natural oil

8000-48-4

Orange oil

Natural oil

8000-57-9

Pine oil

Natural oil

8002-09-3

Black pepper oil

Natural oil

8006-82-4

Peppermint oil

Natural oil

8006-90-4

Lemongrass oil

Natural oil

8007-02-1

Penny Royal Oil

Natural oil

8007-44-1

Thyme oil

Natural oil

8007-46-3

Coriander oil

Natural oil

8008-52-4

Spearmint oil

Natural oil

8008-75-5

Valeriana officinalis oil

Natural oil

8008-88-6

Cajuput Oil

Natural oil

8008-98-8

Juniperberry oil

Natural oil

8012-91-7

Cypress Oil

Natural oil

8013-86-3

Patchouli oil

Natural oil

8014-09-3

Cumin Oil

Natural oil

8014-13-9

Palmarosa oil

Natural oil

8014-19-5

Rue oil

Natural oil

8014-29-7

Basilicum Ocimum basilium oil

Natural oil

8015-73-4

Bois de rose oil/Rosewood oil

Natural oil

8015-77-8

Celery oil

Natural oil

8015-90-5

Chamomile oil

Natural oil

8015-92-7

Clove leaf oil (Eugenia caryophyllus)

Natural oil

8015-97-2

Melaleuca oil

Natural oil

68647-73-4

Litsea cubeba oil

Natural oil

68855-99-2

Cornmint oil

Natural oil

68917-18-0

Cedar Oil (Cedarwood oil Texas, Juniperus mexicana oil, 22 %)

Natural oil

68990-83-0

Citrus extract of seeds of tabebuia avellanedae

Natural oil

 

Essential oil of cymbopogon winterianus

Natural oil

 

Allium sativum and Allium cepa

Natural oil

 

Essential oil of cinnamomum zeylanicum

Natural oil

 

Clove oil (main components: Eugenol (83,8 %), Caryophyllene (12,4 %), Eugenol acetate (0,4 %))

Natural oil

 

Fir needle perfume oil: (Ethereal oil, main components: Turpentine oil (30-37,5 %), Terpineol (15-20 %), Isobornyl acetate (15-20 %), Pinene beta (12,5-15 %), Pinene alpha (7-10 %), Coumarin (1-3 %), Terpineol-fraction (1-3%)

Natural oil

 

Perfume oil Spring Fresh: ethereal oil: main components: Citral-diethylacetal (Citrathal) (1-3 %), Citronellol (1-3 %), Ylanat (1-3 %), Hivertal (1-3 %), Allylcapronate (1-3 %)

Natural oil

 

Rosas oil

Natural oil

 

Natural Pyrethrins

Natural extract

 

Peat extract

Natural extract

 

Alkyl-benzyl-dimethylammonium chloride/Benzalkonium chloride

Mixture

8001-54-5

Cetrimide

Mixture

8044-71-1

Mixture of 3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8;) and 3,6-acridinediamine/Acriflavine

Mixture

8048-52-0

Mixture of ((3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8) and 3,6-acridinediamine) hydrochloride)/Acriflavine HCl

Mixture

8063-24-9

Benzalkonium saccharinate/Benzalkonium o-sulfobenzimidate

Mixture

39387-42-3

Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)

Mixture

55965-84-9

Siloxanes and Silicones, di-Me, reaction products with silica/Treated Fumed Silica

Mixture

67762-90-7

Reaction mixture of fatty acids mixed esters (C6-18, derived from coconut oil) with acetic acid and 2,2′-methylenebis(4-chlorophenol)

Mixture

106523-52-8

Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid

Mixture

139734-65-9

Quaternary ammonium iodides

Mixture

308074-50-2

Reaction products of 5,5-dimethylhydantoin and formaldehyde

Mixture

 

Reaction products of 2-(2-butoxyethoxy)ethanol and formaldehyde

Mixture

 

Reaction products of ethylene glycol and formaldehyde

Mixture

 

Reaction products of urea, ethylene glycol and formaldehyde

Mixture

 

Reaction products of chloroacetamide, 2(2-butoxyethoxy)ethanol and formaldehyde

Mixture

 

Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4)

Mixture

 

Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situ

Mixture

 

Potassium salts of fatty acids (C15-21)

Mixture

 

Acypetacs copper

Mixture

 

Acypetacs zinc

Mixture

 

Webbing clothes moths pheromone: components: E,Z-Octadecadi-2,13-enal (75 %) and E-Octadec-2-enal (25 %)

Mixture

 

Mixture of chromium trioxide (EINECS 215-607-8; 34,2 %), diarsenic pentoxide (EINECS 215-116-9; 24,1 %), copper(II)oxide (EINECS 215-269-1; 13,7 %), water (EINECS 231-791-2; 28 %)

Mixture

 

Mixture of chlormethylisothiazolinon, ethandiylbisoxybismethanol, methylisothiazolinon

Mixture

 

Mixture of bromine (EINECS 231-778-1) and hypobromous acid (CAS-No.: 13517-11-8) manufactured in situ

Mixture

 

Products of natural fermentation of plants in water, sulphur-containing

Mixture

 

Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKC

Mixture of EINECS listed substances

 

Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC

Mixture of EINECS listed substances

 

Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMAC

Mixture of EINECS listed substances

 

Bacillus thuringiensis

Micro-organism

68038-71-1

Bacillus sphaericus

Micro-organism

143447-72-7

Bacillus thuringiensis +D381is subsp. Israelensis

Micro-organism

 

Bacillus thuringiensis Var. Kurstaky

Micro-organism

 

Bacillus thuringiensis subsp. Israelensis Serotype H14

Micro-organism

 

Bacillus thuringiensis var. israelensis

Micro-organism

 

Bacillus subtilis

Micro-organism

 


(1)  This substance also has a different CAS number (31654-77-0) according to the ESIS registry.


ANNEX II

ACTIVE SUBSTANCES TO BE EXAMINED UNDER THE REVIEW PROGRAMME

Substance

Rapporteur Member State

EC number

CAS number

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

Formaldehyde

DE

200-001-8

50-00-0

1

2

3

4

5

6

 

 

9

 

11

12

13

 

 

 

 

 

 

20

 

22

23

2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide

EL

200-076-7

51-03-6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

19

 

 

 

 

Bronopol

ES

200-143-0

52-51-7

1

2

3

4

 

6

7

 

9

10

11

12

13

 

 

 

 

 

 

 

 

22

 

Diphenoxarsin-10-yl oxide

FR

200-377-3

58-36-6

 

 

 

 

 

 

 

 

9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chlorocresol

FR

200-431-6

59-50-7

1

2

3

4

 

6

 

 

9

10

 

 

13

 

 

 

 

 

 

 

 

 

 

Dichlorvos

IT

200-547-7

62-73-7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

Ethanol

EL

200-578-6

64-17-5

1

2

3

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Formic acid

BE

200-579-1

64-18-6

1

2

3

4

5

6

 

 

9

 

11

12

13

 

 

 

 

 

 

 

 

 

 

Benzoic acid

DE

200-618-2

65-85-0

1

2

3

4

 

6

 

 

 

 

11

 

 

 

 

 

 

 

 

20

 

 

 

Propan-2-ol

DE

200-661-7

67-63-0

1

2

3

4

5

6

 

 

9

10

11

12

 

 

 

 

 

 

 

 

 

 

 

Salicylic acid

LT

200-712-3

69-72-7

1

2

3

4

 

6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Propan-1-ol

DE

200-746-9

71-23-8

1

2

3

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hydrogen cyanide

CZ

200-821-6

74-90-8

 

 

 

 

 

 

 

8

 

 

 

 

 

14

 

 

 

18

 

 

 

 

 

Ethylene oxide

N

200-849-9

75-21-8

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20

 

 

 

1,3-dibromo-5,5-dimethylhydantoin

NL

201-030-9

77-48-5

 

2

 

 

 

 

 

 

 

 

11

12

 

 

 

 

 

 

 

 

 

 

 

Citric acid

BE

201-069-1

77-92-9

1

2

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Linalool

DK

201-134-4

78-70-6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19

 

 

 

 

2-chloroacetamide

EE

201-174-2

79-07-2

 

 

3

 

 

6

7

 

9

10

11

 

13

 

 

 

 

 

 

 

 

 

 

Bromoacetic acid

ES

201-175-8

79-08-3

 

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Glycollic acid

LT

201-180-5

79-14-1

 

2

3

4

 

 

 

 

 

 

 

12

 

 

 

 

 

 

 

 

 

 

 

Peracetic acid

FI

201-186-8

79-21-0

1

2

3

4

5

6

 

 

 

 

11

12

 

 

 

 

 

 

 

 

 

 

 

L-(+)-lactic acid

DE

201-196-2

79-33-4

 

2

3

4

 

6

 

 

 

 

 

 

 

 

 

 

 

 

 

20

 

 

 

Warfarin

IE

201-377-6

81-81-2

 

 

 

 

 

 

 

 

 

 

 

 

 

14

 

 

 

 

 

 

 

 

 

(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one/Rotenone

UK

201-501-9

83-79-4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17

 

 

 

 

 

 

Symclosene

UK

201-782-8

87-90-1

 

2

3

4

5

6

7

 

9

 

11

12

 

 

 

 

 

 

 

 

 

 

 

Chloroxylenol

BE

201-793-8

88-04-0

1

2

3

4

5

6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Biphenyl-2-ol

ES

201-993-5

90-43-7

1

2

3

4

 

6

7

 

9

10

 

 

13

 

 

 

 

 

 

 

 

 

 

Naphthalene

UK

202-049-5

91-20-3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19

 

 

 

 

Dichlorophen

IE

202-567-1

97-23-4

 

2

3

4

 

6

7

 

9

10

11

12

13

 

 

 

 

 

 

 

 

 

 

Triclocarban

SK

202-924-1

101-20-2

1

2

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cinnamaldehyde/3-phenyl-propen-2-al

UK

203-213-9

104-55-2

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Geraniol

FR

203-377-1

106-24-1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

19

 

 

 

 

Glyoxal

FR

203-474-9

107-22-2

 

2

3

4

 

6

 

 

 

 

 

12

 

 

 

 

 

 

 

 

 

 

 

m-Cresol

FR

203-577-9

108-39-4

 

2

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hexa-2,4-dienoic acid/Sorbic acid

DE

203-768-7

110-44-1

1

2

3

4

5

6

7

8

9

10

 

 

 

 

 

 

 

 

 

 

 

 

 

Glutaral

FI

203-856-5

111-30-8

1

2

3

4

5

6

7

 

9

10

11

12

13

 

 

 

 

 

 

 

 

22

 

Nonanoic acid

AT

203-931-2

112-05-0

 

2

 

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

19

 

 

 

 

Undecan-2-one/Methyl-nonyl-ketone

ES

203-937-5

112-12-9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19

 

 

 

 

Propoxur

BE

204-043-8

114-26-1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

1,3-dichloro-5,5-dimethylhydantoin

NL

204-258-7

118-52-5

 

2

 

 

 

 

 

 

 

 

11

12

 

 

 

 

 

 

 

 

 

 

 

Clorophene

N

204-385-8

120-32-1

1

2

3

4

 

6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Benzyl benzoate

UK

204-402-9

120-51-4

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

Benzethonium chloride

BE

204-479-9

121-54-0

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fenitrothion

UK

204-524-2

122-14-5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

Cetalkonium chloride (1)

 

204-526-3

122-18-9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Benzyldimethyl(octadecyl)ammonium chloride (1)

 

204-527-9

122-19-0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2-Phenoxyethanol

UK

204-589-7

122-99-6

1

2

3

4

 

6

7

 

 

10

11

 

13

 

 

 

 

 

 

 

 

 

 

Cetylpyridinium chloride

UK

204-593-9

123-03-5

1

2

3

4

5

6

7

 

9

 

 

 

 

 

 

 

 

 

 

20

 

 

 

Octanoic acid

AT

204-677-5

124-07-2

 

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

Carbon dioxide

FR

204-696-9

124-38-9

 

 

 

 

 

 

 

 

 

 

 

 

 

14

15

 

 

18

19

20

 

 

 

Sodium dimethylarsinate

PT

204-708-2

124-65-2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

Nitromethylidynetrimethanol

UK

204-769-5

126-11-4

 

2

3

 

 

6

 

 

 

 

11

12

13

 

 

 

 

 

 

 

 

 

 

Tosylchloramide sodium

ES

204-854-7

127-65-1

1

2

3

4

5

6

 

 

9

10

11

 

 

 

 

 

 

 

 

 

 

 

 

Potassium dimethyldithiocarbamate

UK

204-875-1

128-03-0

 

2

 

4

 

6

 

 

9

10

11

12

13

 

 

 

 

 

 

 

 

 

 

Sodium dimethyldithiocarbamate

UK

204-876-7

128-04-1

 

2

3

4

5

6

 

 

9

10

11

12

13

 

 

 

 

 

 

 

 

 

 

Warfarin sodium

IE

204-929-4

129-06-6

 

 

 

 

 

 

 

 

 

 

 

 

 

14

 

 

 

 

 

 

 

 

 

Sodium 2-biphenylate

ES

205-055-6

132-27-4

1

2

3

4

 

6

7

 

9

10

 

 

13

 

 

 

 

 

 

 

 

 

 

Captan

IT

205-087-0

133-06-2

 

 

 

 

 

6

7

 

9

10

 

 

 

 

 

 

 

 

 

 

 

 

 

N-(trichloromethylthio)phthalimide/Folpet

IT

205-088-6

133-07-3

 

 

 

 

 

6

7

 

9

10

 

 

 

 

 

 

 

 

 

 

 

 

 

Methyl anthranilate

FR

205-132-4

134-20-3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19

 

 

 

 

N,N-diethyl-m-toluamide

SE

205-149-7

134-62-3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19

 

 

22

 

Thiram

BE

205-286-2

137-26-8

 

2

 

 

 

6

7

 

9

10

11

12

 

 

 

 

 

 

 

 

 

 

 

Ziram

BE

205-288-3

137-30-4

 

2

 

 

 

6

7

 

9

10

11

12

 

 

 

 

 

 

 

 

 

 

 

Potassium methyldithiocarbamate

CZ

205-292-5

137-41-7

 

2

 

 

 

 

 

 

9

 

11

12

 

 

 

 

 

 

 

 

 

 

 

Metam-sodium

BE

205-293-0

137-42-8

 

2

 

4

 

6

 

 

9

 

11

12

13

 

 

 

 

 

 

20

 

 

 

Disodium cyanodithiocarbamate

CZ

205-346-8

138-93-2

 

2

 

 

 

 

 

 

9

 

11

12

 

 

 

 

 

 

 

 

 

 

 

Benzododecinium chloride (1)

 

205-351-5

139-07-1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Miristalkonium chloride (1)

 

205-352-0

139-08-2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,3-bis(hydroxymethyl)urea

HU

205-444-0

140-95-4

 

2

 

 

 

6

 

 

9

 

11

12

13

 

 

 

 

 

 

 

 

 

 

Nabam

PL

205-547-0

142-59-6

 

2

 

4

 

6

 

 

9

10

11

12

13

 

 

 

 

 

 

 

 

 

 

Lauric acid

DE

205-582-1

143-07-7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19

 

 

 

 

Thiabendazole

ES

205-725-8

148-79-8

 

2

 

 

 

6

7

8

9

10

11

12

13

 

 

 

 

 

 

20

 

 

 

Benzothiazole-2-thiol

N

205-736-8

149-30-4

 

2

 

 

 

 

7

 

9

 

11

12

13

 

 

 

 

 

 

 

 

 

 

Naled

FR

206-098-3

300-76-5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

Diuron

DK

206-354-4

330-54-1

 

 

 

 

 

6

7

 

 

10

 

 

 

 

 

 

 

 

 

 

 

 

 

Diazinon

PT

206-373-8

333-41-5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

Decanoic acid

AT

206-376-4

334-48-5

 

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

18

19

 

 

 

 

Cyanamide

DE

206-992-3

420-04-2

 

 

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one

SK

207-880-7

499-44-5

 

 

 

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

 

 

 

 

 

Sodium benzoate

DE

208-534-8

532-32-1

1

2

 

 

 

6

 

 

 

 

11

 

 

 

 

 

 

 

 

20

 

 

 

Dazomet

BE

208-576-7

533-74-4

 

 

 

 

 

6

7

8

9

10

11

12

 

 

 

 

 

 

 

 

 

 

 

Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid

FI

211-986-9

731-27-1

 

 

 

 

 

 

7

8

 

10

 

 

 

 

 

 

 

 

 

 

21

 

 

Hydroxyl-2-pyridone

FR

212-506-0

822-89-9

 

2

 

 

 

6

 

 

9

10

11

12

13

 

 

 

 

 

 

 

 

 

 

2,6-dimethyl-1,3-dioxan-4-yl acetate

AT

212-579-9

828-00-2

 

2

 

 

 

6

 

 

 

 

11

12

13

 

 

 

 

 

 

 

 

 

 

Terbutryn

SK

212-950-5

886-50-0

 

 

 

 

 

 

7

 

9

10

 

 

 

 

 

 

 

 

 

 

 

 

 

Dichlofluanid

UK

214-118-7

1085-98-9

 

 

 

 

 

 

7

8

 

10

 

 

 

 

 

 

 

 

 

 

21

 

 

Copper thiocyanate

FR

214-183-1

1111-67-7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

21

 

 

Tetradonium bromide

N

214-291-9

1119-97-7

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-Tetramethrin

DE

214-619-0

1166-46-7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

 

 

4,5-dichloro-3H-1,2-dithiol-3-one

PL

214-754-5

1192-52-5

 

2

 

 

 

6

 

 

9

 

11

12

 

 

 

 

 

 

 

 

 

 

 

Diboron trioxide

NL

215-125-8

1303-86-2

 

 

 

 

 

 

 

8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked lime

UK

215-137-3

1305-62-0

 

2

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calcium oxide/lime/burnt lime/quicklime

UK

215-138-9

1305-78-8

 

2

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Zinc sulphide

UK

215-251-3

1314-98-3

 

 

 

 

 

 

7

 

9

10

 

 

 

 

 

 

 

 

 

 

 

 

 

Copper oxide

FR

215-269-1

1317-38-0

 

 

 

 

 

 

 

8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dicopper oxide

FR

215-270-7

1317-39-1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

21

 

 

Disodium tetraborate, anhydrous

NL

215-540-4

1330-43-4

1

2

 

 

 

 

7

8

9

10

11

 

13

 

 

 

 

 

 

 

 

 

 

2-Butanone, peroxide

HU

215-661-2

1338-23-4

1

2

3

 

 

6

 

 

9

 

 

 

 

 

 

 

 

 

 

 

 

22

 

Monolinuron

UK

217-129-5

1746-81-2

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,4-dichlorobenzyl alcohol

CZ

217-210-5

1777-82-8

 

2

 

 

 

6

7

 

9

10

 

12

13

 

 

 

 

 

 

 

 

 

 

Chlorothalonil

NL

217-588-1

1897-45-6

 

 

 

 

 

6

7

 

9

10

 

 

 

 

 

 

 

 

 

 

 

 

 

Fluometuron

EL

218-500-4

2164-17-2

 

 

 

 

 

6

7

 

9

10

11

12

13

 

 

 

 

 

 

 

 

 

 

4-(2-nitrobutyl)morphol